NEXTGEN HEALTHCARE, INC. - Quarter Report: 2010 June (Form 10-Q)
Table of Contents
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 10-Q
þ | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the quarterly period ended June 30, 2010
or
o | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
Commission file number: 001-12537
QUALITY SYSTEMS, INC.
(Exact name of Registrant as specified in its charter)
California | 95-2888568 | |
(State or Other Jurisdiction of | (IRS Employer | |
Incorporation or Organization) | Identification No.) |
18111 Von Karman Avenue, Suite 600, Irvine, California | 92612 | |
(Address of principal executive offices) | (Zip Code) |
Registrants telephone number, including area code: (949) 255-2600
Indicate by check mark whether the Registrant (1) has filed all reports required to be filed
by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding twelve months
(or for such shorter period that the Registrant was required to file such reports), and (2) has
been subject to such filing requirements for the past ninety days. Yes þ No o
Indicate by check mark whether the registrant has submitted electronically and posted on its
corporate Web site, if any, every Interactive Data File required to be submitted and posted
pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months
(or for such shorter period that the registrant was required to submit and post such files). Yes þ No o
Indicate by check mark whether the Registrant is a large accelerated filer, an accelerated filer,
or a non-accelerated filer, or a smaller reporting company. See the definitions of large
accelerated filer, accelerated filer and smaller reporting company in Rule 12b-2 of the
Exchange Act. (Check one):
Large accelerated filer þ | Accelerated filer o | Non-accelerated filer o (Do not check if a smaller reporting company) | Smaller reporting company o |
Indicate by check mark whether the Registrant is a shell company (as defined in Rule 12b-2 of the
Exchange Act). Yes o No þ
Indicate the number of shares outstanding of each of the Registrants classes of Common Stock as of
the latest practicable date. 28,911,098 shares of Common Stock, $0.01 par value, outstanding as of
July 29, 2010
QUALITY SYSTEMS, INC.
FORM 10-Q
For the Quarterly Period Ended June 30, 2010
For the Quarterly Period Ended June 30, 2010
INDEX
2
Table of Contents
PART I
CONSOLIDATED FINANCIAL INFORMATION
CONSOLIDATED FINANCIAL INFORMATION
ITEM 1. FINANCIAL STATEMENTS
QUALITY SYSTEMS, INC.
CONSOLIDATED BALANCE SHEETS
(IN THOUSANDS, EXCEPT PER SHARE DATA)
(UNAUDITED)
CONSOLIDATED BALANCE SHEETS
(IN THOUSANDS, EXCEPT PER SHARE DATA)
(UNAUDITED)
June 30, 2010 | March 31, 2010 | |||||||
ASSETS |
||||||||
Current assets: |
||||||||
Cash and cash equivalents |
$ | 93,208 | $ | 84,611 | ||||
Restricted cash |
2,253 | 2,339 | ||||||
Marketable securities |
7,700 | 7,158 | ||||||
Accounts receivable, net |
111,532 | 107,458 | ||||||
Inventories, net |
1,393 | 1,340 | ||||||
Income taxes receivable |
| 2,953 | ||||||
Deferred income taxes, net |
5,479 | 5,678 | ||||||
Other current assets |
7,950 | 8,684 | ||||||
Total current assets |
229,515 | 220,221 | ||||||
Equipment and improvements, net |
8,348 | 8,432 | ||||||
Capitalized software costs, net |
12,422 | 11,546 | ||||||
Intangibles, net |
19,380 | 20,145 | ||||||
Goodwill |
46,189 | 46,189 | ||||||
Other assets |
3,970 | 3,647 | ||||||
Total assets |
$ | 319,824 | $ | 310,180 | ||||
LIABILITIES AND SHAREHOLDERS EQUITY |
||||||||
Current liabilities: |
||||||||
Accounts payable |
$ | 4,523 | $ | 3,342 | ||||
Deferred revenue |
63,565 | 64,109 | ||||||
Accrued compensation and related benefits |
7,596 | 8,951 | ||||||
Income taxes payable |
3,843 | | ||||||
Dividends payable |
8,673 | 8,664 | ||||||
Other current liabilities |
16,941 | 16,220 | ||||||
Total current liabilities |
105,141 | 101,286 | ||||||
Deferred revenue, net of current |
804 | 474 | ||||||
Deferred income taxes, net |
10,398 | 10,859 | ||||||
Deferred compensation |
1,954 | 1,883 | ||||||
Other noncurrent liabilities |
7,436 | 7,389 | ||||||
Total liabilities |
125,733 | 121,891 | ||||||
Commitments and contingencies (Note 14) |
||||||||
Shareholders equity: |
||||||||
Common stock |
||||||||
$0.01 par value; authorized 50,000 shares; issued and
outstanding 28,911 and 28,879 shares at June 30, 2010 and
March 31, 2010, respectively |
289 | 289 | ||||||
Additional paid-in capital |
124,655 | 122,271 | ||||||
Retained earnings |
69,147 | 65,729 | ||||||
Total shareholders equity |
194,091 | 188,289 | ||||||
Total liabilities and shareholders equity |
$ | 319,824 | $ | 310,180 | ||||
The accompanying notes are an integral part of these consolidated financial statements.
3
Table of Contents
QUALITY SYSTEMS, INC.
CONSOLIDATED STATEMENTS OF INCOME
(IN THOUSANDS, EXCEPT PER SHARE DATA)
(UNAUDITED)
CONSOLIDATED STATEMENTS OF INCOME
(IN THOUSANDS, EXCEPT PER SHARE DATA)
(UNAUDITED)
Three Months Ended June 30, | ||||||||
2010 | 2009 | |||||||
Revenues: |
||||||||
Software, hardware and supplies |
$ | 24,756 | $ | 17,776 | ||||
Implementation and training services |
4,308 | 3,457 | ||||||
System sales |
29,064 | 21,233 | ||||||
Maintenance |
25,536 | 21,640 | ||||||
Electronic data interchange services |
9,764 | 8,161 | ||||||
Revenue cycle management and related services |
10,772 | 8,992 | ||||||
Other services |
7,791 | 6,612 | ||||||
Maintenance, EDI, RCM and other services |
53,863 | 45,405 | ||||||
Total revenues |
82,927 | 66,638 | ||||||
Cost of revenue: |
||||||||
Software, hardware and supplies |
6,212 | 2,704 | ||||||
Implementation and training services |
2,990 | 2,881 | ||||||
Total cost of system sales |
9,202 | 5,585 | ||||||
Maintenance |
3,454 | 3,025 | ||||||
Electronic data interchange services |
6,709 | 5,890 | ||||||
Revenue cycle management and related services |
8,145 | 6,522 | ||||||
Other services |
4,349 | 4,867 | ||||||
Total cost of maintenance, EDI, RCM and other services |
22,657 | 20,304 | ||||||
Total cost of revenue |
31,859 | 25,889 | ||||||
Gross profit |
51,068 | 40,749 | ||||||
Operating expenses: |
||||||||
Selling, general and administrative |
26,238 | 20,093 | ||||||
Research and development costs |
5,456 | 3,977 | ||||||
Amortization of acquired intangible assets |
347 | 357 | ||||||
Total operating expenses |
32,041 | 24,427 | ||||||
Income from operations |
19,027 | 16,322 | ||||||
Interest income |
60 | 78 | ||||||
Other income (expense) |
(6 | ) | 58 | |||||
Income before provision for income taxes |
19,081 | 16,458 | ||||||
Provision for income taxes |
6,989 | 6,112 | ||||||
Net income |
$ | 12,092 | $ | 10,346 | ||||
Net income per share: |
||||||||
Basic |
$ | 0.42 | $ | 0.36 | ||||
Diluted |
$ | 0.42 | $ | 0.36 | ||||
Weighted-average shares outstanding: |
||||||||
Basic |
28,896 | 28,492 | ||||||
Diluted |
29,057 | 28,635 | ||||||
Dividends declared per common share |
$ | 0.30 | $ | 0.30 |
The accompanying notes are an integral part of these consolidated financial statements.
4
Table of Contents
QUALITY SYSTEMS, INC.
CONSOLIDATED STATEMENTS OF CASH FLOWS
(IN THOUSANDS)
(UNAUDITED)
CONSOLIDATED STATEMENTS OF CASH FLOWS
(IN THOUSANDS)
(UNAUDITED)
Three Months Ended June 30, | ||||||||
2010 | 2009 | |||||||
Cash flows from operating activities: |
||||||||
Net income |
$ | 12,092 | $ | 10,346 | ||||
Adjustments to reconcile net income to net cash provided by
operating activities: |
||||||||
Depreciation |
962 | 886 | ||||||
Amortization of capitalized software costs |
1,669 | 1,440 | ||||||
Amortization of other intangibles |
765 | 357 | ||||||
Provision for bad debts |
850 | 852 | ||||||
Share-based compensation |
1,065 | 462 | ||||||
Deferred income tax benefit |
(262 | ) | (514 | ) | ||||
Tax benefit associated with stock options |
175 | 797 | ||||||
Excess tax benefit from share-based compensation |
(175 | ) | (797 | ) | ||||
Changes in assets and liabilities: |
||||||||
Accounts receivable |
(4,924 | ) | (3,212 | ) | ||||
Inventories |
(53 | ) | (26 | ) | ||||
Income taxes receivable |
2,953 | 4,534 | ||||||
Other current assets |
278 | 788 | ||||||
Other assets |
(323 | ) | 292 | |||||
Accounts payable |
1,181 | (751 | ) | |||||
Deferred revenue |
(214 | ) | (1,476 | ) | ||||
Accrued compensation and related benefits |
(1,355 | ) | (1,059 | ) | ||||
Income taxes payable |
3,843 | | ||||||
Other current liabilities |
721 | 2,345 | ||||||
Deferred compensation |
71 | 250 | ||||||
Other noncurrent liabilities |
47 | | ||||||
Net cash provided by operating activities |
19,366 | 15,514 | ||||||
Cash flows from investing activities: |
||||||||
Additions to capitalized software costs |
(2,545 | ) | (1,420 | ) | ||||
Additions to equipment and improvements |
(878 | ) | (1,669 | ) | ||||
Net cash used in investing activities |
(3,423 | ) | (3,089 | ) | ||||
Cash flows from financing activities: |
||||||||
Excess tax benefit from share-based compensation |
175 | 797 | ||||||
Proceeds from exercise of stock options |
1,144 | 2,554 | ||||||
Dividends paid |
(8,665 | ) | (8,532 | ) | ||||
Net cash used in financing activities |
(7,346 | ) | (5,181 | ) | ||||
Net increase in cash and cash equivalents |
8,597 | 7,244 | ||||||
Cash and cash equivalents at beginning of period |
84,611 | 70,180 | ||||||
Cash and cash equivalents at end of period |
$ | 93,208 | $ | 77,424 | ||||
Supplemental disclosures of cash flow information: |
||||||||
Cash paid during the period for income taxes, net of
refunds |
$ | 276 | $ | 1,278 | ||||
The accompanying notes are an integral part of these consolidated financial statements.
5
Table of Contents
QUALITY SYSTEMS, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(IN THOUSANDS, EXCEPT SHARES AND PER SHARE DATA)
(UNAUDITED)
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(IN THOUSANDS, EXCEPT SHARES AND PER SHARE DATA)
(UNAUDITED)
1. Basis of Presentation
The accompanying unaudited consolidated financial statements as of June 30, 2010 and for the three
months ended June 30, 2010 and 2009, have been prepared in accordance with the requirements of Form
10-Q and Article 10 of Regulation S-X, and therefore do not include all information and notes which
would be presented were such consolidated financial statements prepared in accordance with
accounting principles generally accepted in the United States of America (GAAP). These
consolidated financial statements should be read in conjunction with the audited consolidated
financial statements presented in the Companys Annual Report on Form 10-K for the fiscal year
ended March 31, 2010. Amounts related to disclosures of March 31, 2010 balances within these
interim consolidated financial statements were derived from the aforementioned Form 10-K. In the
opinion of management, the accompanying consolidated financial statements reflect all adjustments
which are necessary for a fair presentation of the results of operations and cash flows for the
periods presented. The results of operations for such interim periods are not necessarily
indicative of results of operations to be expected for the full year.
2. Summary of Significant Accounting Policies
Principles of Consolidation. The consolidated financial statements include the accounts of Quality
Systems, Inc. and its wholly-owned subsidiaries, which consists of NextGen Healthcare Information
Systems (NextGen), Lackland Acquisition II, LLC dba Healthcare Strategic Initiatives (HSI),
Practice Management Partners, Inc. (PMP), NextGen Sphere, LLC (Sphere), and Opus Healthcare
Solutions, Inc. (Opus). All significant intercompany accounts and transactions have been
eliminated.
Business Segments. The Company has prepared operating segment information in accordance with FASB
ASC Topic 280, Segment Reporting, or ASC 280, which requires that companies disclose operating
segments based on the manner in which management disaggregates the Companys operations for making
internal operating decisions. See Note 12.
Basis of Presentation. The accompanying consolidated financial statements have been prepared in
accordance with GAAP.
Certain prior period amounts have been reclassified to conform with fiscal year 2011 presentation.
References to dollar amounts in the consolidated financial statement sections are in thousands,
except shares and per share data, unless otherwise specified.
Revenue Recognition. The Company recognizes revenue for system sales pursuant to FASB ASC Topic
985-605, Software, Revenue Recognition, or ASC 985-605. The Company generates revenue from the
sale of licensing rights to its software products directly to end-users and value-added resellers,
or VARs. The Company also generates revenue from sales of hardware and third party software,
implementation, training, Electronic Data Interchange (EDI), post-contract support (maintenance),
and other services, including revenue cycle management (RCM), performed for customers who license
its products.
A typical system contract contains multiple elements of the above items. FASB ASC Topic
985-605-25, Software, Revenue Recognition, Multiple Elements, or ASC 985-605-25, requires revenue
earned on software arrangements involving multiple elements to be allocated to each element based
on the relative fair values of those elements. The fair value of an element must be based on
vendor specific objective evidence (VSOE). The Company limits its assessment of VSOE for each
element to either the price charged when the same element is sold separately or the price
established by management having the relevant authority to do so, for an element not yet sold
separately. VSOE calculations are updated and reviewed quarterly or annually depending on the
nature of the product or service. The Company has established VSOE for the related undelivered
elements based on the bell-shaped curve method. Maintenance VSOE for the Companys largest
customers is based on stated renewal rates only if the rate is determined to be substantive and
falls within the Companys customary pricing practices.
When evidence of fair value exists for the delivered and undelivered elements of a transaction,
then discounts for individual elements are aggregated and the total discount is allocated to the
individual elements in proportion to the elements fair value relative to the total contract fair
value.
When evidence of fair value exists for the undelivered elements only, the residual method, provided
for under ASC 985-605, is used. Under the residual method, the Company defers revenue related to
the undelivered elements in a system sale based on VSOE of fair value of each of the undelivered
elements, and allocates the remainder of the contract price net of all discounts to revenue
recognized from the delivered elements. If VSOE of fair value of any undelivered element does not
exist, all revenue is deferred until VSOE of fair value of the undelivered element is established
or the element has been delivered.
The Company bills for the entire system sales contract amount upon contract execution except for
maintenance which is billed separately. Amounts billed in excess of the amounts contractually due
are recorded in accounts receivable as advance billings. Amounts are contractually due when
services are performed or in accordance with contractually specified payment dates. Provided the
fees are fixed or determinable and collection is considered probable, revenue from licensing rights
and sales of hardware and third party software is generally recognized upon physical or electronic
shipment and transfer of title. In certain transactions where collections risk is high, the cash
basis method is used to recognize revenue. If the fee is not fixed or determinable, then the
revenue recognized in each period (subject
to application of other revenue recognition criteria) will be the lesser of the aggregate of
amounts due and payable or the amount of the
6
Table of Contents
arrangement fee that would have been recognized if the
fees were being recognized using the residual method. Fees which are considered fixed or
determinable at the inception of the Companys arrangements must include the following
characteristics:
| The fee must be negotiated at the outset of an arrangement, and generally be based on the specific volume of products to be delivered without being subject to change based on variable pricing mechanisms such as the number of units copied or distributed or the expected number of users. | |
| Payment terms must not be considered extended. If a significant portion of the fee is due more than 12 months after delivery or after the expiration of the license, the fee is presumed not fixed or determinable. |
Revenue from implementation and training services is recognized as the corresponding services are
performed. Maintenance revenue is recognized ratably over the contractual maintenance period.
Contract accounting is applied where services include significant software modification,
development or customization. In such instances, the arrangement fee is accounted for in
accordance with FASB ASC Topic 605-35, Revenue Recognition, Construction-Type and Production-Type
Contracts, or ASC 605-35. Pursuant to ASC 605-35, the Company uses the percentage of completion
method provided all of the following conditions exist:
| the contract includes provisions that clearly specify the enforceable rights regarding goods or services to be provided and received by the parties, the consideration to be exchanged, and the manner and terms of settlement; | |
| the customer can be expected to satisfy its obligations under the contract; | |
| the Company can be expected to perform its contractual obligations; and | |
| reliable estimates of progress towards completion can be made. |
The Company measures completion using labor input hours. Costs of providing services, including
services accounted for in accordance with ASC 605-35, are expensed as incurred.
If a situation occurs in which a contract is so short term that the financial statements would not
vary materially from using the percentage-of-completion method or in which the Company is unable to
make reliable estimates of progress of completion of the contract, the completed contract method is
utilized.
Product returns are estimated in accordance with FASB ASC Topic 605-15, Revenue Recognition,
Products, or ASC 605-15. The Company also ensures that the other criteria in ASC 605-15 have been
met prior to recognition of revenue:
| the price is fixed or determinable; | |
| the customer is obligated to pay and there are no contingencies surrounding the obligation or the payment; | |
| the customers obligation would not change in the event of theft or damage to the product; | |
| the customer has economic substance; | |
| the amount of returns can be reasonably estimated; and | |
| the Company does not have significant obligations for future performance in order to bring about resale of the product by the customer. |
The Company has historically offered short-term rights of return in certain sales arrangements. If
the Company is able to estimate returns for these types of arrangements, revenue is recognized, net
of an allowance for returns, and these arrangements are recorded in the consolidated financial
statements. If the Company is unable to estimate returns for these types of arrangements, revenue
is not recognized in the consolidated financial statements until the rights of return expire.
Revenue related to sales arrangements that include the right to use software stored on the
Companys hardware is accounted for under FASB ASC Topic 985-605-05, Software, Revenue Recognition,
Hosting Arrangements, or ASC 985-605-05, which requires that for software licenses and related
implementation services to continue to fall under ASC 985-605-05, the customer must have the
contractual right to take possession of the software without incurring a significant penalty and it
must be feasible for the customer to either host the software themselves or through another third
party. If an arrangement is not deemed to be accounted for under ASC 985-605-05, the entire
arrangement is accounted for as a service contract in accordance with ASC 985-605-25. In that
instance, the entire arrangement would be recognized during the period that the hosting services
are being performed.
From time to time, the Company offers future purchase discounts on its products and services as
part of its sales arrangements. Pursuant to FASB ASC Topic 985-605-55, Software, Revenue
Recognition, Flowchart of Revenue Recognition on Software Arrangements, or ASC 985-605-55, such
discounts that are incremental to the range of discounts reflected in the pricing of the other
elements of the arrangement, that are incremental to the range of discounts typically given in
comparable transactions, and that are significant, are treated as an additional element of the
contract to be deferred. Amounts deferred related to future purchase options are not recognized
until either the customer exercises the discount offer or the offer expires.
RCM service revenue is derived from services fees, which include amounts charged for ongoing
billing and other related services, and are generally billed to the customer as a percentage of
total collections. The Company does not recognize revenue for services fees until these
collections are made, as the services fees are not fixed or determinable until such time.
Revenue is divided into two categories, system sales and maintenance, EDI, RCM and other
services. Revenue in the system sales category includes software license fees, third party
hardware and software, and implementation and training services related to purchase of
the Companys software systems. Revenue in the maintenance, EDI, RCM and other services category
includes maintenance, EDI, RCM services, follow on training and implementation services, annual
third party license fees, hosting services and other services revenue.
7
Table of Contents
Cash and Cash Equivalents. Cash and cash equivalents generally consist of cash, money market funds
and short-term U.S. Treasury securities with original maturities of less than 90 days. The money
market fund in which the Company holds a portion of its cash invests in only investment grade money
market instruments from a variety of industries, and therefore bears relatively low market risk.
The average maturity of the investments owned by the money market fund is approximately two months.
Restricted Cash. Restricted cash consists of cash which is being held by HSI acting as agent for
the disbursement of certain state social services programs. The Company records an offsetting
Care Services liability (see also Note 4) when it initially receives such cash from the
government social service programs and relieves both restricted cash and the Care Services
liability when amounts are disbursed. HSI earns an administrative fee which is based on a
percentage of funds disbursed on behalf of certain government social service programs.
Marketable Securities and ARS Put Option Rights. Marketable securities are recorded at fair value,
based on quoted market rates or valuation analysis when appropriate.
The Companys investments at June 30, 2010 and March 31, 2010 are in tax exempt municipal Auction
Rate Securities (ARS), which are classified as either current or non-current marketable
securities depending on the liquidity and timing of expected realization of such securities. The
ARS are rated by one or more national rating agencies and have contractual terms of up to 30 years,
but generally have interest rate reset dates that occur every 7, 28 or 35 days. Despite the
underlying long-term maturity of ARS, such securities were priced and subsequently traded as
short-term investments because of the interest rate reset feature. If there are insufficient
buyers, the auction is said to fail and the holders are unable to liquidate the investments
through auction. A failed auction does not result in a default of the debt instrument. Under
their respective terms, the securities will continue to accrue interest and be auctioned until the
auction succeeds, the issuer calls the securities or the securities mature. In February 2008, the
Company began to experience failed auctions on its ARS.
The Companys ARS are held by UBS Financial Services Inc. (UBS). On November 13, 2008, the
Company entered into an Auction Rate Security Rights Agreement (the Rights Agreement) with UBS,
whereby the Company accepted UBSs offer to purchase the Companys ARS investments at any time
during the period of June 30, 2010 through July 2, 2012. As a result, the Company had obtained an
asset, ARS put option rights, whereby the Company had a right to put the ARS back to UBS.
Prior to signing the Rights Agreement, the Company had asserted that it had the intent and ability
to hold these securities until anticipated recovery and classified its ARS as held for sale
securities. By accepting the Rights Agreement, the Company could no longer assert that it has the
intent to hold the auction rate securities until anticipated recovery and consequently elected to
reclassify its investments in ARS as trading securities, as defined by FASB ASC Topic 320,
Investments Debt and Equity Securities, or ASC 320, on the date of Companys acceptance of the
Rights Agreement. As trading securities, the ARS were carried at fair value with changes recorded
through earnings.
To determine the estimated fair values of the ARS, factors including credit quality, assumptions
about the likelihood of redemption, observable market data such as yields or spreads of fixed rate
municipal bonds and other trading instruments issued by the same or comparable issuers, were
considered. The Company had valued the ARS as the approximate midpoint between various fair
values, measured as the difference between the par value of the ARS and the fair value of the
securities, discounted by the credit risk of the broker and other factors such as the Companys
historical experience to sell ARS at par.
As the Company was permitted to put the ARS back to UBS at par value, the Company accounted for the
ARS put option right as a separate asset that was measured at its fair value with changes recorded
through earnings. The Company had valued the ARS put option right as the approximate midpoint
between various fair values, measured as the difference between the par value of the ARS and the
fair value of the securities, discounted by the credit risk of the broker and other factors such as
the Companys historical experience to sell ARS at par.
On June 30, 2010, the earliest date allowable under the Rights Agreement, the Company exercised its
ARS put option rights and put its ARS back to UBS. The ARS were sold and settled on July 1, 2010
at 100% of the $7,700 par value. The Company has determined that the par value of $7,700
approximates the fair value of its ARS investments and ARS put option rights on June 30, 2010.
Allowance for Doubtful Accounts. The Company provides credit terms typically ranging from thirty
days to less than twelve months for most system and maintenance contract sales and generally does
not require collateral. The Company performs credit evaluations of its customers and maintains
reserves for estimated credit losses. Reserves for potential credit losses are determined by
establishing both specific and general reserves. Specific reserves are based on managements
estimate of the probability of collection for certain troubled accounts. General reserves are
established based on the Companys historical experience of bad debt expense and the aging of the
Companys accounts receivable balances, net of deferred revenue and specifically reserved accounts.
Accounts are written off as uncollectible only after the Company has expended extensive collection
efforts.
Included in accounts receivable are amounts related to maintenance and services which were billed,
but which had not yet been rendered as of the end of the period. Undelivered maintenance and
services are included as a component of deferred revenue (see also Note 4).
Inventories. Inventories consist of hardware for specific customer orders and spare parts, and are
valued at lower of cost (first-in, first-out) or market. Management provides a reserve to reduce
inventory to its net realizable value.
Equipment and Improvements. Equipment and improvements are stated at cost less accumulated
depreciation and amortization. Depreciation and amortization of equipment and improvements are
provided over the estimated useful lives of the assets, or the related lease terms if shorter, by
the straight-line method. Useful lives range as follows:
|
Computers and electronic test equipment | 3-5 years | ||
8
Table of Contents
|
Furniture and fixtures | 5-7 years | ||
|
Leasehold improvements | lesser of lease term or estimated useful life of asset |
Software Development Costs. Development costs incurred in the research and development of new
software products and enhancements to existing software products are expensed as incurred until
technological feasibility has been established. After technological feasibility is established,
any additional development costs are capitalized in accordance with FASB ASC Topic 985-20,
Software, Costs of Computer Software to be Sold, Leased or Marketed, or ASC 985-20. Such
capitalized costs are amortized on a straight-line basis over the estimated economic life of the
related product, which is typically three years. The Company provides support services on the
current and prior two versions of its software. Management performs an annual review of the
estimated economic life and the recoverability of such capitalized software costs. If a
determination is made that capitalized amounts are not recoverable based on the estimated cash
flows to be generated from the applicable software, any remaining capitalized amounts are written
off.
Goodwill. Goodwill is related to NextGen and the HSI, PMP, Sphere, and Opus acquisitions, which
closed on May 20, 2008, October 28, 2008, August 12, 2009, and February 10, 2010, respectively (see
Notes 5 and 6). In accordance with FASB ASC Topic 350-20, Intangibles Goodwill and Other,
Goodwill, or ASC 350-20, the Company tests goodwill for impairment annually at the end of its first
fiscal quarter, referred to as the annual test date. The Company will also test for impairment
between annual test dates if an event occurs or circumstances change that would indicate the
carrying amount may be impaired. Impairment testing for goodwill is performed at a reporting-unit
level, which is defined as an operating segment or one level below and operating segment (referred
to as a component). A component of an operating segment is a reporting unit if the component
constitutes a business for which discrete financial information is available and segment management
regularly reviews the operating results of that component.
The Company has determined that NextGen, HSI, and PMP each qualify as a separate reporting unit
level while Sphere and Opus are aggregated as one reporting unit at which goodwill impairment
testing is performed.
Determining the fair value of a reporting unit involves the use of significant estimates and
assumptions. The estimate of fair value of each of the Companys reporting units is based on
projection of revenues, cost of services, other expenses and cash flows considering historical and
estimated future results, general economic and market conditions as well as the impact of planned
business and operational strategies. The Company determines its fair value estimates using
assumptions it believes to be reasonable at the time, but such assumptions are subject to inherent
uncertainty. Actual results may differ from those estimates. The valuations employ present value
techniques to measure fair value and consider market factors.
For HSI, PMP, Sphere, and Opus, fair value was determined based upon a combination of various
valuation techniques, including an income approach, which utilizes discounted future cash flow
projections based upon managements 5-year forecasts, a market approach, which is based upon
pricing multiples at which similar companies have been sold, and a cost approach where an analysis
of assets and liabilities is performed to restate each to fair value, then determining enterprise
value from the difference between current assets and current liabilities. Key assumptions used to
determine the fair value of each reporting unit as the Companys annual assessment date were: (a)
expected cash flow for the period from 2011 to 2016 plus a terminal year; (b) a discount rate of
18%-25%, which is based on marketplace participant expectations; and (c) a debt-free net cash flow
long-term growth rate of 4% which is based on expected levels of growth for nominal GDP and
inflation.
The estimated fair value of NextGen was determined using an estimate of future cash flows over both
5 and 10 year periods and risk adjusted discount rates of between 10 and 25 percent to compute a
net present value of discounted future cash flows.
An impairment loss would generally be recognized when the carrying amount of the reporting units
net assets exceeds the estimated fair value of the reporting unit. Based on its analysis, the
Company has determined that there was no impairment to its goodwill as of June 30, 2010. See also
Note 6.
Intangible Assets. Intangible assets consist of capitalized software costs, customer
relationships, trade names and certain intellectual property. Intangible assets related to
customer relationships, trade names, and software technology arose in connection with the
acquisition of HSI, PMP, Sphere, and Opus. These intangible assets were recorded at fair value and
are stated net of accumulated amortization. Intangible assets are amortized over their remaining
estimated useful lives, ranging from 3 to 9 years. The Companys amortization policy for
intangible assets is based on the principles in FASB ASC Topic 350-30, Intangibles Goodwill and
Other, General Intangibles Other than Goodwill, or ASC 350-30, which requires that the amortization
of intangible assets reflect the pattern that the economic benefits of the intangible assets are
consumed.
Long-Lived Assets. The Company assesses the recoverability of long-lived assets at least annually
or whenever adverse events or changes in circumstances indicate that impairment may have occurred
in accordance with FASB ASC Topic 360-10, Property, Plant, and Equipment, Impairment or Disposal of
Long-Lived Assets, or ASC 360-10. If the future undiscounted cash flows expected to result from
the use of the related assets are less than the carrying value of such assets, impairment has been
incurred and a loss is recognized to reduce the carrying value of the long-lived assets to fair
value, which is determined by discounting estimated future cash flows.
Management periodically reviews the carrying value of long-lived assets to determine whether or not
impairment to such value has occurred and has determined that there was no risk of impairment to
its long-lived assets as of June 30, 2010. In addition to the recoverability assessment, the
Company routinely reviews the remaining estimated lives of its long-lived assets.
Income Taxes. The Company accounts for income taxes in accordance with FASB ASC Topic 740, Income
Taxes, or ASC 740. Income taxes are provided based on current taxable income and the future tax
consequences of temporary differences between the basis of assets and liabilities for financial and
tax reporting. The deferred income tax assets and liabilities represent the future state and
federal tax return
9
Table of Contents
consequences of those differences, which will either be taxable or deductible
when the assets and liabilities are recovered or settled. Deferred income taxes are also
recognized for operating losses that are available to offset future taxable income and tax credits
that are available to offset future income taxes. At each reporting period, management assesses
the realizable value of deferred tax assets based on, among other things, estimates of future
taxable income, and adjusts the related valuation allowance as necessary. Management makes a
number of assumptions and estimates in determining the appropriate amount of expense to record for
income taxes. These assumptions and estimates consider the taxing jurisdiction in which the
Company operates as well as current tax regulations. Accruals are established for estimates of tax
effects for certain transactions and future projected profitability of the Companys businesses
based on managements interpretation of existing facts and circumstances.
Self-Insurance Liabilities. Effective January 1, 2010, the Company became self-insured with
respect to healthcare claims, subject to stop-loss limits. The Company accrues for estimated
self-insurance costs and uninsured exposures based on claims filed and an estimate of claims
incurred but not reported as of each balance sheet date. However, it is possible that recorded
accruals may not be adequate to cover the future payment of claims. Adjustments, if any, to
estimated accruals resulting from ultimate claim payments will be reflected in earnings during the
periods in which such adjustments are determined. Periodically, the Company reevaluates the
adequacy of the accruals by comparing amounts accrued on the balance sheets for anticipated losses
to an updated actuarial loss forecasts and third party claim administrator loss estimates and makes
adjustments to the accruals as needed. The self-insurance accrual is included in other current
liabilities. If any of the factors that contribute to the overall cost of insurance claims were to
change, the actual amount incurred for the self-insurance liabilities would be directly affected.
Advertising Costs. Advertising costs are charged to operations as incurred. The Company does not
have any direct-response advertising. Advertising costs are included in selling, general and
administrative expenses.
Marketing Assistance Agreements. The Company has entered into marketing assistance agreements with
certain existing users of the Companys products, which provide the opportunity for those users to
earn commissions if they host specific site visits upon the Companys request for prospective
customers that directly result in a purchase of the Companys software by the visiting prospects.
Amounts earned by existing users under this program are treated as a selling expense in the period
when earned.
Share-Based Compensation. FASB ASC Topic 718 Compensation Stock Compensation, or ASC 718,
requires companies to estimate the fair value of share-based payment awards on the date of grant
using an option-pricing model. Expected term is estimated using historical exercise experience.
Volatility is estimated by using the weighted-average historical volatility of the Companys Common
Stock, which approximates expected volatility. The risk free rate is the implied yield available
on the U.S Treasury zero-coupon issues with remaining terms equal to the expected term. The
expected dividend yield is the average dividend rate during a period equal to the expected term of
the option. Those inputs are then entered into the Black Scholes model to determine the estimated
fair value. The value of the portion of the award that is ultimately expected to vest is
recognized ratably as expense over the requisite service period in the Companys consolidated
statements of income.
The following table shows total stock-based compensation expense included in the consolidated
statements of income for the three months ended June 30, 2010 and 2009.
Three Months Ended June 30, | ||||||||
2010 | 2009 | |||||||
Costs and expenses: |
||||||||
Cost of revenue |
$ | 68 | $ | 13 | ||||
Research and development |
28 | 19 | ||||||
Selling, general and administrative |
969 | 430 | ||||||
Total share-based compensation |
1,065 | 462 | ||||||
Amounts capitalized in software development costs |
(1 | ) | (13 | ) | ||||
Amounts charged against earnings, before income tax benefit |
$ | 1,064 | $ | 449 | ||||
Related income tax benefit |
(348 | ) | (797 | ) | ||||
(Increase) decrease in net income |
$ | 716 | $ | (348 | ) | |||
Newly Adopted Accounting Standards
In January 2010, the FASB issued Accounting Standards Update, or ASU, 2010-06, Fair Value
Measurements and Disclosures (Topic 820) Improving Disclosures about Fair Value Measurements, or
ASU 2010-06, to require additional disclosures about recurring or nonrecurring fair value
measurements, including significant transfers into and out of Level 1 and Level 2 fair value
measurements and information on purchases, sales, issuances, and settlements on a gross basis in
the reconciliation of Level 3 fair value measurements. The
standard also clarifies existing disclosures about the level of disaggregation, valuation
techniques and inputs to fair value measurements. The provisions of ASU 2010-06 are effective for
interim and annual reporting periods beginning after December 15, 2009, except for the Level 3
reconciliation disclosures that are effective for fiscal years beginning after December 15, 2010,
and for interim periods within those fiscal years. The Company adopted the provisions of ASU
2010-06 regarding Level 1 and Level 2 fair value measurements during the quarter ended June 30,
2010. As the Company did not have any transfers between Level 1 and Level 2 fair value
measurement, the adoption of this standard did not have a material effect on the Companys
consolidated financial statements. The Company does not expect the future adoption of the
provisions for Level 3 reconciliation to have a significant impact on its consolidated financial
statements.
10
Table of Contents
Recently Issued Accounting Standards
In September 2009, the FASB reached a consensus on ASU 2009-13, Revenue Recognition (Topic 605)
Multiple-Deliverable Revenue Arrangements, or ASU 2009-13, and ASU 2009-14, Software (Topic 985)
Certain Revenue Arrangements That Include Software Elements, or ASU 2009-14. ASU 2009-13 modifies
the requirements that must be met for an entity to recognize revenue from the sale of a delivered
item that is part of a multiple-element arrangement when other items have not yet been delivered.
ASU 2009-13 eliminates the requirement that all undelivered elements must have either: (a) VSOE or
(b) third-party evidence, or TPE, before an entity can recognize the portion of an overall
arrangement consideration that is attributable to items that already have been delivered. In the
absence of VSOE or TPE of the standalone selling price for one or more delivered or undelivered
elements in a multiple-element arrangement, entities will be required to estimate the selling
prices of those elements. Overall arrangement consideration will be allocated to each element
(both delivered and undelivered items) based on their relative selling prices, regardless of
whether those selling prices are evidenced by VSOE or TPE or are based on the entitys estimated
selling price. The residual method of allocating arrangement consideration has been eliminated.
ASU 2009-14 modifies the software revenue recognition guidance to exclude from its scope tangible
products that contain both software and non-software components that function together to deliver a
products essential functionality. These new updates are effective for revenue arrangements
entered into or materially modified in fiscal years beginning on or after June 15, 2010. Early
adoption is permitted. The Company is currently evaluating the impact that the adoption of these
ASUs will have on its consolidated financial statements.
3. Fair Value Measurements
The Company applies ASC 820 with respect to fair value measurements of (a) nonfinancial assets and
liabilities that are recognized or disclosed at fair value in the Companys consolidated financial
statements on a recurring basis (at least annually) and (b) all financial assets and liabilities.
As defined by ASC 820, fair value is the price that would be received to sell an asset or paid to
transfer a liability (an exit price) in the principal or most advantageous market for the asset or
liability in an orderly transaction between market participants on the measurement date. The
Company estimates fair value utilizing market data or assumptions that market participants would
use in pricing the asset or liability in a current transaction, including assumptions about risk
and the risks inherent in the inputs to the valuation technique. ASC 820 prioritizes the inputs
used in measuring fair value into the following hierarchy (with Level 1 as the highest priority):
Level 1 | Quoted market prices in active markets for identical assets or liabilities; | |
Level 2 | Observable inputs other than those included in Level 1 (for example, quoted prices for similar assets in active markets or quoted prices for identical assets in inactive markets); and | |
Level 3 | Unobservable inputs reflecting managements own assumptions about the inputs used in estimating the value of the asset. |
Recurring Fair Value Measurements
The fair value hierarchy requires the use of observable market data when available. The financial
assets and liabilities are classified in their entirety based on the lowest level of input that is
significant to the fair value measurement. The Companys assessment of the significance of a
particular input to the fair value measurement requires judgment and may affect the valuation of
fair value assets and liabilities and their placement within the fair value hierarchy levels. The
following tables sets forth by level within the fair value hierarchy the Companys financial assets
and liabilities that were accounted for at fair value on a recurring basis at June 30, 2010 and
March 31, 2010:
11
Table of Contents
Quoted Prices | ||||||||||||||||
in Active | Significant | |||||||||||||||
Markets for | Other | |||||||||||||||
Identical | Observable | Unobservable | ||||||||||||||
Balance at | Assets | Inputs | Inputs | |||||||||||||
June 30, 2010 | (Level 1) | (Level 2) | (Level 3) | |||||||||||||
Cash and cash equivalents |
$ | 93,208 | $ | 93,208 | $ | | $ | | ||||||||
Restricted cash |
2,253 | 2,253 | | | ||||||||||||
Marketable securities (1) |
7,700 | | | 7,700 | ||||||||||||
$ | 103,161 | $ | 95,461 | $ | | $ | 7,700 | |||||||||
(1) | Marketable securities consist of ARS and ARS put option rights. |
Quoted Prices | ||||||||||||||||
in Active | Significant | |||||||||||||||
Markets for | Other | |||||||||||||||
Identical | Observable | Unobservable | ||||||||||||||
Balance at | Assets | Inputs | Inputs | |||||||||||||
March 31, 2010 | (Level 1) | (Level 2) | (Level 3) | |||||||||||||
Cash and cash equivalents |
$ | 84,611 | $ | 84,611 | $ | | $ | | ||||||||
Restricted cash |
2,339 | 2,339 | | | ||||||||||||
Marketable securities (2) |
7,158 | | | 7,158 | ||||||||||||
ARS put option rights (3) |
548 | | | 548 | ||||||||||||
$ | 94,656 | $ | 86,950 | $ | | $ | 7,706 | |||||||||
(2) | Marketable securities consist of ARS. | |
(3) | ARS put option rights are included in other current assets. |
On June 30, 2010, the earliest date allowable under the Rights Agreement, the Company exercised
its ARS put option rights and put its ARS back to UBS. The ARS were sold and settled on July 1,
2010 at 100% of the $7,700 par value. The Company has determined that the par value of $7,700
approximates the fair value of its ARS investments and ARS put option rights on June 30, 2010. The
resulting net loss for the fair value adjustment on June 30, 2010 of $6 is included in other income
(expense).
The following table presents activity in the Companys assets measured at fair value using
significant unobservable inputs (Level 3), as defined by ASC 820, as of and for the three months
ended June 30, 2010:
Balance at March 31, 2010 |
$ | 7,706 | ||
Transfer in/(out) of Level 3 |
| |||
Proceeds from sale (at par) |
| |||
Recognized loss |
(6 | ) | ||
Balance at June 30, 2010 |
$ | 7,700 | ||
Non-Recurring Fair Value Measurements
The Company has certain assets, including inventories, tangible fixed assets, goodwill and other
intangible assets, which are measured at fair value on a non-recurring basis and are adjusted to
fair value only when the carrying values are more than the fair values. The categorization of the
framework used to price the assets is considered a Level 3, due to the subjective nature of the
unobservable inputs used to determine the fair value. During the three months ended June 30, 2010,
there were no adjustments to fair value of such assets.
Fair Value of Financial Instruments
The estimated fair value of financial instruments is determined using the best available market
information and appropriate valuation methodologies. However, considerable judgment is necessary
in interpreting market data to develop the estimates of fair value. Accordingly, the estimates
presented are not necessarily indicative of the amounts that the Company could realize in a current
market exchange, or the value that ultimately will be realized upon maturity or disposition. The
use of different market assumptions may have a material effect on the estimated fair value amounts.
The Companys financial instruments, other than those presented in the disclosures above, include
cash and cash equivalents, accounts receivables, accounts payable, and accrued liabilities. The
carrying value of these assets and liabilities approximates fair value because of the short-term
nature of these instruments.
4. Composition of Certain Financial Statement Captions
Accounts receivable include amounts related to maintenance and services that were billed but not
yet rendered at each period end. Undelivered maintenance and services are included as a component
of the deferred revenue balance.
12
Table of Contents
June 30, 2010 | March 31, 2010 | |||||||
Accounts receivable, excluding undelivered software,
maintenance and services |
$ | 77,936 | $ | 72,500 | ||||
Undeliverable software, maintenance and implementation
services billed in advance, included in deferred revenue |
38,664 | 39,447 | ||||||
Accounts receivable, gross |
116,600 | 111,947 | ||||||
Allowance for doubtful accounts |
(5,068 | ) | (4,489 | ) | ||||
Accounts receivable, net |
$ | 111,532 | $ | 107,458 | ||||
Inventories are summarized as follows:
June 30, 2010 | March 31, 2010 | |||||||
Computer systems and components, net of reserve for
obsolescence of $237 |
$ | 1,384 | $ | 1,322 | ||||
Miscellaneous parts and supplies |
9 | 18 | ||||||
Inventories, net |
$ | 1,393 | $ | 1,340 | ||||
Equipment and improvements are summarized as follows:
June 30, 2010 | March 31, 2010 | |||||||
Computer and electronic test equipment |
$ | 19,213 | $ | 18,599 | ||||
Furniture and fixtures |
5,357 | 5,136 | ||||||
Leasehold improvements |
2,012 | 1,969 | ||||||
26,582 | 25,704 | |||||||
Accumulated depreciation and amortization |
(18,234 | ) | (17,272 | ) | ||||
Equipment and improvements, net |
$ | 8,348 | $ | 8,432 | ||||
Current and non-current deferred revenue are summarized as follows:
June 30, 2010 | March 31, 2010 | |||||||
Maintenance |
$ | 11,830 | $ | 13,242 | ||||
Implementation services |
41,130 | 38,137 | ||||||
Annual license services |
7,293 | 8,214 | ||||||
Undelivered software and other |
3,312 | 4,516 | ||||||
Deferred revenue |
$ | 63,565 | $ | 64,109 | ||||
Deferred revenue, net of current |
$ | 804 | $ | 474 | ||||
Accrued compensation and related benefits are summarized as follows:
June 30, 2010 | March 31, 2010 | |||||||
Payroll, bonus and commission |
$ | 2,542 | $ | 4,185 | ||||
Vacation |
5,054 | 4,766 | ||||||
Accrued compensation and related benefits |
$ | 7,596 | $ | 8,951 | ||||
Other current liabilities are summarized as follows:
13
Table of Contents
June 30, 2010 | March 31, 2010 | |||||||
Contingent consideration related to acquisition |
$ | 4,900 | $ | 5,275 | ||||
Care services liabilities |
2,251 | 2,336 | ||||||
Accrued EDI expense |
2,065 | 2,000 | ||||||
Sales tax payable |
992 | 506 | ||||||
Customer deposits |
898 | 1,036 | ||||||
Accrued royalties |
607 | 926 | ||||||
Commission payable |
521 | 468 | ||||||
Users Group Meeting (UGM) |
449 | 8 | ||||||
Deferred rent |
449 | 641 | ||||||
Self insurance reserve |
425 | 516 | ||||||
Professional services |
384 | 391 | ||||||
Other accrued expenses |
3,000 | 2,117 | ||||||
Other current liabilities |
$ | 16,941 | $ | 16,220 | ||||
5. Business Combinations
On February 10, 2010, the Company acquired Opus, a provider of clinical information systems to the
small hospital inpatient market, and on August 12, 2009, the Company acquired Sphere, a provider of
financial information systems to the small hospital inpatient market.
The Company accounted for these acquisitions as a purchase business combination as defined in FASB
ASC Topic 805, Business Combinations, or ASC 805. Under the acquisition method of accounting, the
purchase price was allocated to the tangible and intangible assets acquired and liabilities assumed
based on their estimated fair values as of the acquisition date. The fair value of the assets
acquired and liabilities assumed represent managements estimate of fair value.
6. Goodwill
In accordance with ASC 350-20, the Company does not amortize goodwill as the goodwill has been
determined to have an indefinite useful life.
Goodwill consists of the following:
June 30, 2010 | March 31, 2010 | |||||||
NextGen Division |
||||||||
Opus Healthcare Solutions, Inc. |
$ | 13,005 | $ | 13,005 | ||||
NextGen Sphere, LLC |
1,020 | 1,020 | ||||||
NextGen Healthcare Information Systems, Inc. |
1,840 | 1,840 | ||||||
Total NextGen Division goodwill |
15,865 | 15,865 | ||||||
Practice Solutions Division |
||||||||
Practice Management Partners, Inc. |
19,485 | 19,485 | ||||||
Healthcare Strategic Initiatives |
10,839 | 10,839 | ||||||
Total Practice Solutions Division goodwill |
30,324 | 30,324 | ||||||
Total goodwill |
$ | 46,189 | $ | 46,189 | ||||
7. Intangible Assets
The Company had the following intangible assets, other than capitalized software development costs,
with determinable lives as of June 30, 2010:
Customer | Software | |||||||||||||||
Relationships | Trade Name | Technology | Total | |||||||||||||
Gross carrying amount |
$ | 10,206 | $ | 637 | $ | 12,119 | $ | 22,962 | ||||||||
Accumulated amortization |
(2,664 | ) | (309 | ) | (609 | ) | (3,582 | ) | ||||||||
Net intangible assets |
$ | 7,542 | $ | 328 | $ | 11,510 | $ | 19,380 | ||||||||
Activity related to the intangible assets for the quarter ended June 30, 2010 is as follows:
14
Table of Contents
Customer | Software | |||||||||||||||
Relationships | Trade Name | Technology | Total | |||||||||||||
Balance as of April 1, 2010 |
$ | 7,849 | $ | 368 | $ | 11,928 | $ | 20,145 | ||||||||
Amortization (1) |
(307 | ) | (40 | ) | (418 | ) | (765 | ) | ||||||||
Balance as of June 30, 2010 |
$ | 7,542 | $ | 328 | $ | 11,510 | $ | 19,380 | ||||||||
(1) | Amortization of the customer relationships and trade name intangible assets is included in operating expenses and amortization of the software technology intangible assets is included in cost of revenue for software, hardware and supplies. |
The following table represents the remaining estimated amortization of intangible assets with
determinable lives as of June 30, 2010:
For the year ended March 31, | ||||
2011 (remaining nine months) |
$ | 2,490 | ||
2012 |
3,320 | |||
2013 |
3,184 | |||
2014 |
3,055 | |||
2015 and beyond |
7,331 | |||
Total |
$ | 19,380 | ||
8. Capitalized Software Costs
The Company had the following amounts related to capitalized software development costs:
June 30, 2010 | March 31, 2010 | |||||||
Gross carrying amount |
$ | 43,974 | $ | 41,429 | ||||
Accumulated amortization |
(31,552 | ) | (29,883 | ) | ||||
Net capitalized software costs |
$ | 12,422 | $ | 11,546 | ||||
Activity related to net capitalized software costs for the quarter ended June 30, 2010 is as
follows:
Balance as of April 1, 2010 |
$ | 11,546 | ||
Capitalized |
2,545 | |||
Amortization |
(1,669 | ) | ||
Balance as of June 30, 2010 |
$ | 12,422 | ||
The following table represents the remaining estimated amortization of capitalized software costs
as of June 30, 2010:
For the year ended March 31, | ||||
2011 (remaining nine months) |
$ | 4,768 | ||
2012 |
4,516 | |||
2013 |
2,743 | |||
2014 |
395 | |||
2015 and beyond |
| |||
Total |
$ | 12,422 | ||
9. Share-Based Awards
Employee Stock Option Plans
In September 1998, the Companys shareholders approved a stock option plan (the 1998 Plan) under
which 4,000,000 shares of Common Stock were reserved for the issuance of options. The 1998 Plan
provides that employees, directors and consultants of the Company may, at the discretion of the
Board of Directors or a duly designated compensation committee, be granted options to purchase
shares of Common
Stock. The exercise price of each option granted was determined by the Board of Directors at the
date of grant, and options under the 1998 Plan expire no later than ten years from the grant date.
Options granted will generally become exercisable in accordance with the terms of the agreement
pursuant to which they were granted. Certain option grants to directors became exercisable three
months from the date of grant. Upon an acquisition of the Company by merger or asset sale, each
outstanding option may be subject to accelerated vesting under certain circumstances. The 1998
Plan terminated on December 31, 2007. As of June 30, 2010, there were 290,080 outstanding options
related to this Plan.
In October 2005, the Companys shareholders approved a stock option and incentive plan (the 2005
Plan) under which 2,400,000 shares of Common Stock were reserved for the issuance of awards,
including stock options, incentive stock options and non-qualified stock
15
Table of Contents
options, stock
appreciation rights, Restricted Stock, Unrestricted Stock, Restricted Stock units, performance
shares, performance units (including performance options) and other share-based awards. The 2005
Plan provides that employees, directors and consultants of the Company may, at the discretion of
the Board of Directors or a duly designated compensation committee, be granted awards to acquire
shares of Common Stock. The exercise price of each option award shall be determined by the Board
of Directors at the date of grant in accordance with the terms of the 2005 Plan, and under the 2005
Plan awards expire no later than ten years from the grant date. Options granted will generally
become exercisable in accordance with the terms of the agreement pursuant to which they were
granted. Upon an acquisition of the Company by merger or asset sale, each outstanding option may
be subject to accelerated vesting under certain circumstances. The 2005 Plan terminates on May 25,
2015, unless terminated earlier by the Board of Directors. At June 30, 2010, 1,728,893 shares were
available for future grant under the 2005 Plan. As of June 30, 2010, there were 532,447
outstanding options related to this Plan.
A summary of stock option transactions during the three months ended June 30, 2010 is as follows:
Weighted- | ||||||||||||||||
Weighted- | Average | Aggregate | ||||||||||||||
Average | Remaining | Intrinsic | ||||||||||||||
Number of | Exercise | Contractual | Value | |||||||||||||
Shares | Price | Life | (in thousands) | |||||||||||||
Outstanding, April 1, 2010 |
871,963 | $ | 43.15 | 4.51 | $ | 15,945 | ||||||||||
Granted |
40,000 | $ | 57.16 | 7.93 | ||||||||||||
Exercised |
(32,707 | ) | $ | 35.01 | 2.67 | $ | 752 | |||||||||
Forfeited/Canceled |
(56,729 | ) | $ | 56.00 | 1.59 | |||||||||||
Outstanding, June 30, 2010 |
822,527 | $ | 43.27 | 4.33 | $ | 12,355 | ||||||||||
Vested and expected to vest, June 30, 2010 |
805,591 | $ | 43.12 | 4.30 | $ | 12,218 | ||||||||||
Exercisable, June 30, 2010 |
309,539 | $ | 33.14 | 2.31 | $ | 7,692 | ||||||||||
The Company continues to utilize the Black-Scholes valuation model for estimating the fair value of
share-based compensation after the adoption of ASC 718 with the following assumptions:
Three Months | ||||
Ended | ||||
June 30, 2010 | ||||
Expected life |
4.2 years | |||
Expected volatility |
44.6% - 44.7 | % | ||
Expected dividends |
2.1 | % | ||
Risk-free rate |
2.0% - 2.1 | % |
During the three months ended June 30, 2010 and 2009, 40,000 and zero (-0-) options were granted,
respectively, under the 2005 Plan. The Company issues new shares to satisfy option exercises.
Based on historical experience of option cancellations, the Company has estimated an annualized
forfeiture rate of 2.4% for employee options and 0.0% for director options. Forfeiture rates will
be adjusted over the requisite service period when actual forfeitures differ, or are expected to
differ, from the estimate. The weighted-average grant date fair value of stock options granted
during the three months ended June 30, 2010 was $18.36 per share. The expected dividend yield is
the average dividend rate during a period equal to the expected life of the option.
On June 4, 2010, the Board of Directors granted a total of 25,000 options under the Companys 2005
Plan to selected employees at an exercise price equal to the market price of the Companys Common
Stock on the date of grant ($56.29 per share). The options vest in five equal annual installments
beginning June 4, 2011 and expire on June 4, 2018.
On June 2, 2010, the Board of Directors granted a total of 15,000 options under the Companys 2005
Plan to a selected employee at an exercise price equal to the market price of the Companys Common
Stock on the date of grant ($58.62 per share). The options vest in five equal annual installments
beginning June 2, 2011 and expire on June 2, 2018.
Performance-Based Awards
On May 26, 2010, the Board of Directors approved its fiscal 2011 equity incentive program for
certain employees to be awarded options to purchase the Companys Common Stock. The maximum number
of options available under the equity incentive program plan is 280,000, of which 115,000 are
reserved for the Companys Named Executive Officers and 165,000 for non-executive employees of the
Company. Under the program, executives are eligible to receive options based on meeting certain
target increases in earnings per share performance and revenue growth during fiscal year 2011.
Under the program, the non-executive employees are eligible to receive options based on satisfying
certain management established criteria and recommendations of senior management. The options
shall be issued pursuant to one of the Companys shareholder approved option plans, have an
exercise price equal to the closing price of the Companys shares on the date of grant, a term of
eight years, and vesting in five equal annual installments commencing one year following the date
of grant.
16
Table of Contents
Compensation expense associated with the performance based awards are initially based on
the number of options expected to vest after assessing the probability that certain performance
criteria will be met. Cumulative adjustments are recorded quarterly to reflect subsequent changes
in the estimated outcome of performance-related conditions. The Company utilized the Black-Scholes
option valuation model and recorded stock compensation expense related to the performance based
awards of approximately $18 during the quarter ended June 30, 2010.
The following assumptions were utilized for performance based awards under the Companys 2011
incentive plan:
Three Months | ||||
Ended | ||||
June 30, 2010 | ||||
Expected life |
4.2 years | |||
Expected volatility |
44.4 | % | ||
Expected dividends |
2.1 | % | ||
Risk-free rate |
1.8 | % |
Non-vested stock option award activity, including employee stock options and performance-based
awards, for the three months ended June 30, 2010, is summarized as follows:
Weighted- | ||||||||
Non-Vested | Average | |||||||
Number of | Fair Value | |||||||
Shares | Price | |||||||
Outstanding, April 1, 2010 |
610,836 | $ | 15.26 | |||||
Granted |
40,000 | $ | 18.36 | |||||
Vested |
(81,119 | ) | $ | 11.54 | ||||
Forfeited/Canceled |
(56,729 | ) | $ | 19.13 | ||||
Outstanding, June 30, 2010 |
512,988 | $ | 15.66 | |||||
As of June 30, 2010, $6,276 of total unrecognized compensation costs related to stock options is
expected to be recognized over a weighted-average period of 5.54 years. This amount does not
include the cost of new options that may be granted in future periods or any changes in the
Companys forfeiture percentage. The total fair value of options vested during the three months
ended June 30, 2010 and 2009 was $936 and $645, respectively.
Restricted Stock Units
On May 27, 2009, the Board of Directors approved its Outside Director Compensation Plan, whereby
each non-employee Director is to be awarded shares of Restricted Stock units upon election or
re-election to the Board. The Restricted Stock units are awarded under the 2005 Plan. Such
Restricted Stock units vest in two equal, annual installments on the first and second anniversaries
of the grant date and are nontransferable for one year following vesting. Upon each vesting of the
award, one share of Common Stock shall be issued for each Restricted Stock unit. The
weighted-average grant date fair value of $54.57 for the Restricted Stock units was estimated using
the market price of its Common Stock on the grant dates of August 13, 2009 and January 27, 2010.
The fair value of these Restricted Stock units is amortized on a straight-line basis over the
vesting period. As of June 30, 2010, 9,146 Restricted Stock units were issued and approximately
$73 of compensation expense was recorded under this Plan during the quarter ended June 30, 2010.
As of June 30, 2010, $290 of total unrecognized compensation costs related to Restricted Stock
units is expected to be recognized over a weighted-average period of 1.12 years. This amount does
not include the cost of new Restricted Stock units that may be granted in future periods or any
changes in the Companys forfeiture percentage. During the quarter ended June 30, 2010, no
Restricted Stock units vested.
10. Income Taxes
The provision for income taxes for the three months ended June 30, 2010 was approximately $6,989 as
compared to approximately $6,112 for the year ago period. The effective tax rates for the three
months ended June 30, 2010 and 2009 were 36.6% and 37.1%, respectively. The provision for income
taxes for the three months ended June 30, 2010 differs from the combined statutory rates primarily
due to the impact of varying state income tax rates, tax-exempt interest income, the qualified
production activities deduction and state research and development tax credits. The effective rate
for the three months ended June 30, 2010 decreased from the prior year primarily due to
fluctuations in the state effective tax rate, increased benefits from the qualified production
activities deduction, and the expiration of the federal research and development tax credit
statute, which occurred at the end of the fourth quarter of fiscal year 2010 and therefore was not
included in the current year first quarter provision.
Uncertain tax positions
As of June 30, 2010, the Company has provided a liability of $659 for unrecognized tax benefits
related to various federal and state income tax matters. If recognized, $659 would impact the
Companys effective tax rate. The reserve for the three months ended June 30, 2010 increased from
the year ago period by $592 due to the addition of prior year tax positions of acquired companies.
17
Table of Contents
The Companys income tax returns filed for tax years 2006 through 2008 and 2005 through 2008 are
subject to examination by the federal and state taxing authorities, respectively. The Company is
currently not under examination by the Internal Revenue Service or any state income tax authority.
The Company does not anticipate that total unrecognized tax benefits will significantly change due
to the settlement of audits or the expiration of statute of limitations within the next twelve
months.
11. Earnings Per Share
Basic net income per share is based upon the weighted-average shares of Common Stock outstanding.
Diluted net income per share is based on the assumption that the Companys outstanding options are
included in the calculation of diluted earnings per share, except when their effect would be
anti-dilutive. Dilution is computed by applying the treasury stock method. Under this method,
options are assumed to be exercised at the beginning of the period (or at the time of issuance, if
later), and as if funds obtained thereby were used to purchase Common Stock at the average market
price during the period. The following table reconciles the weighted-average shares outstanding
for basic and diluted net income per share for the periods indicated (in thousands):
Three Months Ended June 30, | ||||||||
2010 | 2009 | |||||||
Net income |
$ | 12,092 | $ | 10,346 | ||||
Basic net income per share: |
||||||||
Weighted-average shares outstanding Basic |
28,896 | 28,492 | ||||||
Basic net income per common share |
$ | 0.42 | $ | 0.36 | ||||
Net income |
$ | 12,092 | $ | 10,346 | ||||
Diluted net income per share: |
||||||||
Weighted-average shares outstanding Basic |
28,896 | 28,492 | ||||||
Effect of potentially dilutive securities |
161 | 143 | ||||||
Weighted-average shares outstanding
Diluted |
29,057 | 28,635 | ||||||
Diluted net income per common share |
$ | 0.42 | $ | 0.36 | ||||
The computation of diluted net income per share does not include 253,000 and 244,000 options for
the three months ended June 30, 2010 and 2009, respectively, because their inclusion would have an
anti-dilutive effect on net income per share.
12. Operating Segment Information
The Company has prepared operating segment information in accordance with ASC 280 to report
components that are evaluated regularly by its chief operating decision maker, or decision making
group, in deciding how to allocate resources and in assessing performance.
As a result of certain organizational changes during fiscal year 2010, the composition of the
Companys NextGen Division was revised to exclude the former NextGen Practice Solutions unit and
the Companys RCM entities (HSI and PMP), both of which are now administered
and aggregated in the Companys Practice Solutions Division. Following the reorganization, the
Company operates three reportable operating segments (not including Corporate), comprised of the
NextGen Division, the QSI Dental Division and the Practice Solutions Division.
Prior period segment results were revised to reflect this reorganization for the Companys NextGen
Division and Practice Solution Division. The results of operations related to the HSI and PMP
acquisitions are included in the Practice Solutions Division. The results of operations related to
the Opus and Sphere acquisitions are included in the NextGen Division.
The QSI Dental Division, co-located with the Companys Corporate Headquarters in Irvine,
California, currently focuses on developing, marketing and supporting software suites sold to
dental and certain niche medical practices. In addition, the Division supports a number of medical
clients that utilize the Divisions UNIX® based medical practice management software
product.
The NextGen Division, with headquarters in Horsham, Pennsylvania, and significant locations in
Atlanta, Georgia and Austin, Texas, focuses principally on developing and marketing products and
services for medical practices.
The Practice Solutions Division, with locations in St. Louis, Missouri and Hunt Valley, Maryland,
focuses primarily on providing physician practices with RCM services, primarily billing and
collection services for medical practices. This Division combines a web-delivered SaaS model and
the NextGenepm software platform to execute its service offerings.
The three Divisions operate largely as stand-alone operations, with each Division maintaining its
own distinct product lines, product platforms, development, implementation and support teams, sales
staffing and branding. The three Divisions share the resources of the Companys corporate office
which includes a variety of accounting and other administrative functions. Additionally, there are
a small but growing number of clients who are simultaneously utilizing software or services from
more than one of its three Divisions.
18
Table of Contents
The accounting policies of the Companys operating segments are the same as those described in Note
2 of our Notes to Consolidated Financial Statements, Summary of Significant Accounting Policies,
except that the disaggregated financial results of the segments reflect allocation of certain
functional expense categories consistent with the basis and manner in which Company management
internally disaggregates financial information for the purpose of assisting in making internal
operating decisions. Certain corporate overhead costs, such as executive and accounting department
personnel-related expenses, are not allocated to the individual segments by management. Management
evaluates performance based on stand-alone segment operating income. Because the Company does not
evaluate performance based on return on assets at the operating segment level, assets are not
tracked internally by segment. Therefore, segment asset information is not presented.
Operating segment data is as follows:
Three Months Ended June 30, | ||||||||
2010 | 2009 | |||||||
Revenue: |
||||||||
QSI Dental Division |
$ | 5,352 | $ | 3,856 | ||||
NextGen Division |
65,830 | 52,430 | ||||||
Practice Solutions Division |
11,745 | 10,352 | ||||||
Consolidated revenue |
$ | 82,927 | $ | 66,638 | ||||
Operating income: |
||||||||
QSI Dental Division |
$ | 1,591 | $ | 664 | ||||
NextGen Division |
22,789 | 19,094 | ||||||
Practice Solutions Division |
187 | 285 | ||||||
Unallocated corporate expense |
(5,540 | ) | (3,721 | ) | ||||
Consolidated operating income |
$ | 19,027 | $ | 16,322 | ||||
All of the recorded goodwill at June 30, 2010 relates to the Companys NextGen Division and
Practice Solutions Division. As a result of the reorganization discussed above, the goodwill
relating to the fiscal year 2009 acquisitions of HSI and PMP is now recorded in the Practice
Solutions Division. The goodwill relating to the acquisitions of Opus and Sphere is recorded in
the NextGen Division.
13. Concentration of Credit Risk
The Company had cash deposits at U.S. banks and financial institutions which exceeded federally
insured limits at June 30, 2010. The Company is exposed to credit loss for amounts in excess of
insured limits in the event of non-performance by the institutions; however, the Company does not
anticipate non-performance by these institutions.
14. Commitments, Guarantees and Contingencies
Commitments and Guarantees
Software license agreements in both the QSI and NextGen Divisions include a performance guarantee
that the Companys software products will substantially operate as described in the applicable
program documentation for a period of 365 days after delivery. To date, the Company has not
incurred any significant costs associated with its performance guarantee or other related
warranties and does not expect to incur significant warranty costs in the future. Therefore, no
accrual has been made for potential costs associated with these warranties. Certain arrangements
also include performance guarantees related to response time, availability for operational use, and
other performance-related guarantees. Certain arrangements also include penalties in the form of
maintenance credits should the performance of the software fail to meet the performance guarantees.
To date, the Company has not incurred any significant costs associated with these warranties and
does not expect to incur significant warranty costs in the future. Therefore, no accrual has been
made for potential costs associated with these warranties.
The Company has historically offered short-term rights of return in certain sales arrangements. If
the Company is able to estimate returns for these types of arrangements and all other criteria for
revenue recognition have been met, revenue is recognized and these arrangements are recorded in the
consolidated financial statements. If the Company is unable to estimate returns for these types of
arrangements, revenue is not recognized in the consolidated financial statements until the rights
of return expire, provided also, that all other criteria of revenue recognition have been met.
The Companys standard sales agreements in the NextGen Division contain an indemnification
provision pursuant to which it shall indemnify, hold harmless, and reimburse the indemnified party
for losses suffered or incurred by the indemnified party in connection with any United States
patent, any copyright or other intellectual property infringement claim by any third party with
respect to its software. The QSI Dental Division arrangements occasionally utilize this type of
language as well. As the Company has not incurred any significant costs to defend lawsuits or
settle claims related to these indemnification agreements, the Company believes that its estimated
exposure on these agreements is currently minimal. Accordingly, the Company has no liabilities
recorded for these indemnification obligations.
The Company has entered into marketing assistance agreements with existing users of the Companys
products which provide the opportunity for those users to earn commissions if they host specific
site visits upon the Companys request for prospective customers that
19
Table of Contents
directly result in a purchase
of the Companys software by the visiting prospects. Amounts earned by existing users under this
program are treated as a selling expense in the period when earned.
Litigation
The Company has experienced legal claims by parties asserting that it has infringed their
intellectual property rights. The Company believes that these claims are without merit and intends
to defend against them vigorously; however, the Company could incur substantial costs and diversion
of management resources defending any infringement claim even if it is ultimately successful in
the defense of such matter. Litigation is inherently uncertain and always difficult to predict.
The Company refers you to the discussion of infringement and litigation risks in the Risk Factors
section of the Companys Annual Report on Form 10-K.
15. Subsequent Events
On July 28, 2010, the Board of Directors approved a quarterly cash dividend of $0.30 per share on
the Companys outstanding shares of Common Stock, payable to shareholders of record as of September
17, 2010 with an expected distribution date on or about October 5, 2010.
20
Table of Contents
ITEM 2. MANAGEMENTS DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
Except for the historical information contained herein, the matters discussed in this managements
discussion and analysis of financial condition and results of operations, or MD&A, including
discussions of our product development plans, business strategies and market factors influencing
our results, may include forward-looking statements that involve certain risks and uncertainties.
Actual results may differ from those anticipated by us as a result of various factors, both
foreseen and unforeseen, including, but not limited to, our ability to continue to develop new
products and increase systems sales in markets characterized by rapid technological evolution,
consolidation, and competition from larger, better capitalized competitors. Many other economic,
competitive, governmental and technological factors could affect our ability to achieve our goals,
and interested persons are urged to review any risks that may be described in Item 1A. Risk
Factors as set forth herein and other risk factors appearing in our most recent filing on our
Annual Report on Form 10-K, as supplemented by additional risk factors, if any, in our interim
filings on our Quarterly Report on Form 10-Q, as well as in our other public disclosures and
filings with the Securities and Exchange Commission.
This MD&A is provided as a supplement to the consolidated financial statements and notes thereto
included in this Quarterly Report on Form 10-Q, in order to enhance your understanding of our
results of operations and financial condition and the following discussion should be read in
conjunction with, and is qualified in its entirety by, the consolidated financial statements and
related notes thereto included elsewhere in this Quarterly Report on Form 10-Q. Historical results
of operations, percentage margin fluctuations and any trends that may be inferred from the
discussion below are not necessarily indicative of the operating results for any future period.
Our MD&A is organized as follows:
| Management Overview. This section provides a general description of our Company and operating segments, a discussion as to how we derive our revenue, background information on certain trends and developments affecting our Company, a summary of our acquisition transactions and a discussion on managements strategy for driving revenue growth. | ||
| Critical Accounting Policies and Estimates. This section discusses those accounting policies that are considered important to the evaluation and reporting of our financial condition and results of operations, and whose application requires us to exercise subjective or complex judgments in making estimates and assumptions. In addition, all of our significant accounting policies, including our critical accounting policies, are summarized in Note 2 of our Notes to Consolidated Financial Statements, Summary of Significant Accounting Policies, included in this Quarterly Report on Form 10-Q. | ||
| Company Overview. This section provides a more detailed description of our Company, operating segments, products and services offered. | ||
| Overview of Results of Operations and Results of Operations by Operating Divisions. These sections provide our analysis and outlook for the significant line items on our consolidated statements of income, as well as other information that we deem meaningful to understand our results of operations on both a consolidated basis and an operating division basis. | ||
| Liquidity and Capital Resources. This section provides an analysis of our liquidity and cash flows. | ||
| New Accounting Pronouncements. This section provides a summary of the most recent authoritative accounting standards and guidance that have either been recently adopted by our Company or may be adopted in the future. |
Management Overview
Quality Systems, Inc., including its wholly-owned subsidiaries, is comprised of the QSI Dental
Division; the NextGen Division, which consists of NextGen Healthcare Information Systems, Inc.
(NextGen), NextGen Sphere, LLC (Sphere) and Opus Healthcare Solutions, Inc. (Opus); and the
Practice Solutions Division, which consists of Lackland Acquisition II, LLC dba Healthcare
Strategic Initiatives (HSI) and Practice Management Partners, Inc. (PMP) (collectively, the
Company, we, our, or us). The Company develops and markets healthcare information systems
that automate certain aspects of medical and dental practices, networks of practices such as
physician hospital organizations (PHOs) and management service organizations (MSOs), ambulatory
care centers, community health centers, and medical and dental schools. The Company also provides
revenue cycle management (RCM) services through the Practice Solutions Division.
The turbulence in the worldwide economy has impacted almost all industries. While healthcare is
not immune to economic cycles, we believe it is more resilient than most segments of the economy.
The impact of the current economic conditions on our existing and prospective clients has been
mixed. We continue to see organizations that are doing fairly well operationally; however, some
organizations with a large dependency on Medicaid populations are being impacted by the challenging
financial condition of the many state governments in whose jurisdictions they conduct business. A
positive factor for U.S. healthcare is the fact that the Obama Administration is pursuing broad
healthcare reform aimed at improving issues surrounding healthcare. The American Recovery and
Reinvestment Act (ARRA), which became law on February 17, 2009, includes more than $20 billion to
help healthcare organizations modernize operations through the acquisition of health care
information technology. While we are unsure of the immediate impact from the ARRA, the long-term
potential could be significant.
On May 20, 2008, we acquired HSI, a full-service healthcare RCM company. HSI operates under the
umbrella of the Companys Practice Solutions Division. Founded in 1996, HSI provides RCM services
to providers including health systems, hospitals, and physicians in private practice with an
in-house team of more than 200 employees, including specialists in medical billing, coding and
compliance, payor credentialing, and information technology.
21
Table of Contents
On October 28, 2008, we acquired PMP, a full-service healthcare RCM company. This acquisition is
also part of our growth strategy for our Practice Solutions Division. Similar to HSI, PMP operates
under the umbrella of the Companys Practice Solutions Division. Founded in 2001, PMP provides
physician billing and technology management services to healthcare providers, primarily in the
Mid-Atlantic region.
On August 12, 2009, we acquired Sphere, a provider of financial information systems to the small
hospital inpatient market. This acquisition is also part of our strategy to expand into the small
hospital market and to add new customers by taking advantage of cross selling opportunities between
the ambulatory and inpatient markets.
On February 10, 2010, we acquired Opus, a provider of clinical information systems to the small
hospital inpatient market. Founded in 1987 and headquartered in Austin, Texas, Opus delivers
web-based clinical solutions to hospital systems and integrated health networks nationwide. This
acquisition complements and will be integrated with the assets of Sphere. Both companies are
established developers of software and services for the inpatient market and will operate under the
Companys NextGen Division.
Our strategy is, at present, to focus on providing software and services to medical and dental
practices. The key elements of this strategy are to continue development and enhancement of select
software solutions in target markets, to continue investments in our infrastructure including but
not limited to product development, sales, marketing, implementation, and support, to continue
efforts to make infrastructure investments within an overall context of maintaining reasonable
expense discipline, to add new customers through maintaining and expanding sales, marketing and
product development activities, and to expand our relationship with existing customers through
delivery of add-on and complementary products and services and to continue our gold standard
commitment of service in support of our customers.
Critical Accounting Policies and Estimates
The discussion and analysis of our consolidated financial statements and results of operations is
based upon our consolidated financial statements, which have been prepared in accordance with
accounting principles generally accepted in the United States of America. The preparation of these
consolidated financial statements requires us to make estimates and judgments that affect the
reported amounts of assets, liabilities, revenue and expenses, and related disclosures of
contingent assets and liabilities. On an on-going basis, we evaluate estimates, including but not
limited to those related to revenue recognition, valuation of marketable securities, ARS put option
rights, uncollectible accounts receivable, software development cost, intangible assets and
self-insurance accruals, for reasonableness. We base our estimates on historical experience and on
various other assumptions that management believes to be reasonable under the circumstances, the
results of which form the basis for making judgments about the carrying values of assets and
liabilities that may not be readily apparent from other sources. Actual results may differ from
these estimates under different assumptions or conditions.
We describe our significant accounting policies in Note 2, Summary of Significant Accounting
Policies, of our Notes to Consolidated Financial Statements included in our Annual Report on Form
10-K for the fiscal year ended March 31, 2010. We discuss our critical accounting policies and
estimates in Item 7, Managements Discussion and Analysis of Financial Condition and Results of
Operations, in our Annual Report on Form 10-K for the fiscal year ended March 31, 2010. There
have been no material changes in our significant accounting policies or critical accounting
policies and estimates since the end of fiscal year 2010.
Company Overview
The Company is comprised of the QSI Dental Division, the NextGen Division, and the Practice
Solutions Division. Operationally, HSI and PMP are considered and administered as part of the
Practice Solutions Division while Opus and Sphere operate under the NextGen Division. We primarily
derive revenue by developing and marketing healthcare information systems that automate certain
aspects of medical and dental practices, networks of practices such as PHOs and MSOs, ambulatory
care centers, community health centers, and medical and dental schools along with comprehensive
systems implementation, maintenance and support and add on complementary services such as RCM and
EDI. Our systems and services provide our clients with the ability to redesign patient care and
other workflow processes while improving productivity through facilitation of managed access to
patient information. Utilizing our proprietary software in combination with third party hardware
and software solutions, our products enable the integration of a variety of administrative and
clinical information operations.
The Company, a California corporation formed in 1974, was founded with an early focus on providing
information systems to dental group practices. In the mid-1980s, we capitalized on the increasing
focus on medical cost containment and further expanded our information processing systems to serve
the medical market. In the mid-1990s, we made two acquisitions that accelerated our penetration
of the medical market. These two acquisitions formed the basis for the NextGen Division. Today,
we serve the medical and dental markets through our NextGen Division and QSI Dental Division.
Historically, the Company has operated principally through two operating divisions: QSI Dental
Division and NextGen Division. Through our acquisitions of HSI and PMP in 2008, we continued to
strengthen our RCM service offerings. During fiscal year 2010, as a result of certain
organizational changes, the composition of the Companys NextGen Division was revised to exclude
the former NextGen Practice Solutions unit and the Companys RCM entities (HSI and PMP), both of
which are now administered and aggregated in the Companys Practice Solutions Division. Following
the reorganization, the Company now operates three reportable operating segments (not including
Corporate), comprised of the NextGen Division, the QSI Dental Division and the Practice Solutions
Division. As a result, our results for the quarter ended June 30, 2009 have been re-casted to
reflect this change.
The following table breaks down our reported segment revenue and segment revenue growth by division
for the three months ended June 30, 2010 and 2009:
22
Table of Contents
Segment Revenue Breakdown | Segment Revenue Growth | |||||||||||||||
For the Three Months Ended June 30, | For the Three Months Ended June 30, | |||||||||||||||
2010 | 2009 | 2010 | 2009 | |||||||||||||
QSI Dental Division |
6.5 | % | 5.8 | % | 38.8 | % | (5.2 | )% | ||||||||
NextGen Division |
79.3 | % | 78.7 | % | 25.6 | % | 2.5 | % | ||||||||
Practice Solutions Division |
14.2 | % | 15.5 | % | 13.5 | % | N/A | |||||||||
Consolidated |
100.0 | % | 100.0 | % | 24.4 | % | 20.7 | % | ||||||||
The QSI Dental Division, co-located with our Corporate Headquarters in Irvine, California,
currently focuses on developing, marketing and supporting software suites sold to dental and
certain niche medical practices. In addition, the Division supports a number of medical clients
that utilize its UNIX® based medical practice management software product and Software
as a Service, or SaaS model, based NextDDS financial and clinical software.
The QSI Dental Divisions practice management software suite utilizes a UNIX® operating
system. Its Clinical Product Suite (CPS) utilizes a Windows NT® operating system and
can be fully integrated with the practice management software from each Division. CPS incorporates
a wide range of clinical tools including, but not limited to, periodontal charting and digital
imaging of X-ray and inter-oral camera images as part of the electronic patient record. The
Division develops, markets, and manages our EDI/connectivity applications. The QSInet Application
Service Provider (ASP/Internet) offering is also developed and marketed by the Division.
In July 2009, we licensed source code from PlanetDDS, Inc. that will allow us to deliver hosted,
web-based SaaS model practice management and clinical software solutions to the dental industry.
The software solution will be marketed primarily to the multi-location dental group practice market
in which the Division has historically been a dominant player. This new software solution
(NextDDS) brings the QSI Dental Division to the forefront of the emergence of internet based
applications and cloud computing and represents a significant growth opportunity for the Division
to sell both to its existing customer base as well as new customers.
The NextGen Division, with headquarters in Horsham, Pennsylvania, and significant locations in
Atlanta, Georgia and Austin, Texas, provides integrated clinical, financial and connectivity
solutions for ambulatory, inpatient and dental provider organizations.
The NextGen Division develops and sells proprietary electronic medical records software and
practice management systems under the NextGen product name. Major product categories of the
NextGen suite include Electronic Health Records (NextGenehr), Enterprise Practice
Management (NextGenepm), Enterprise Appointment Scheduling (NextGeneas),
Enterprise Master Patient Index (NextGenepi), NextGen Image Control System
(NextGenics), Managed Care Server (NextGenmcs), Electronic Data
Interchange, System Interfaces, Internet Operability (NextGenweb), a Patient-centric
and Provider-centric Web Portal solution (NextMD.com), NextGen Express, a scaled-down version of
NextGenehr designed for small practices and NextGen Community Health Solution
(NextGenchs). The NextGen Division also offers optional NextGen Hosting Solutions to
new and existing customers. NextGen products utilize Microsoft Windows technology and can operate
in a client-server environment as well as via private intranet, the Internet, or in an ASP
environment.
The Practice Solutions Division, with locations in St. Louis, Missouri and Hunt Valley, Maryland,
focuses primarily on providing physician practices with RCM services, primarily billing and
collection services for medical practices. This Division combines a web-delivered SaaS model and
the NextGenepm software platform to execute its service offerings. We intend to
transition our customer base onto the NextGen platform within the next two years. The Practice
Solutions Division provides technology solutions and consulting services to cover the full spectrum
of providers revenue cycle needs from patient access to claims denials.
The three Divisions operate largely as stand-alone operations, with each Division maintaining its
own distinct product lines, product platforms, development, implementation and support teams, sales
staffing and branding. The three Divisions share the resources of our corporate office, which
includes a variety of accounting and other administrative functions. Additionally, there are a
small but growing number of clients who are simultaneously utilizing software or services from more
than one of our three Divisions.
The Divisions develop and market practice management software that is designed to automate and
streamline a number of the administrative functions required for operating a medical or dental
practice. Examples of practice management software functions include scheduling and billing
capabilities. It is important to note that in both the medical and dental environments, practice
management software systems have already been implemented by the vast majority of practices.
Therefore, we actively compete for the replacement market.
In addition, the Divisions develop and market software that automates the patient record. Adoption
rates for this software, commonly referred to as clinical software, are relatively low. Therefore,
we are typically competing to replace paper-based patient record alternatives as opposed to
replacing previously purchased systems.
We make available EDI capabilities and connectivity services to our customers. The
EDI/connectivity capabilities encompass direct interfaces between our products and external third
party systems, as well as transaction-based services. EDI products are intended to automate a
number of manual, often paper-based or telephony intensive communications between patients and/or
providers and/or payors. Two of the more common EDI services are forwarding insurance claims
electronically from providers to payors and assisting practices with issuing statements to
patients. Most client practices utilize at least some of these services from us or one of our
competitors. Other EDI/connectivity services are used more sporadically by client practices. We
typically compete to displace incumbent vendors for claims
and statements accounts and attempt to increase usage of other elements in our EDI/connectivity
product line. In general, EDI services are only sold to those accounts utilizing software from
either the QSI Dental or NextGen Divisions.
23
Table of Contents
We continue to pursue product and service enhancement initiatives within each Division. The
majority of such expenditures are currently targeted to the NextGen Division product line and
client base.
Overview of Our Results
| Consolidated revenue increased 24.4% and income from operations grew by 16.6% in the three months ended June 30, 2010 versus the same period in 2009. For the three months ended June 30, 2010, revenue was positively impacted by growth in recurring revenue, including maintenance, EDI and RCM revenue, which grew 18.0%, 19.6% and 19.8%, respectively, offset by higher corporate expenses. | |
| Income from operations was negatively impacted by a shift in revenue mix with an increased share of hardware, EDI, and RCM revenue, resulting in a decline in our gross profit margin. We also experienced higher selling, general and administrative expenses primarily due to higher selling related expenses incurred in preparation for the ARRA, which was enacted in February 2009, as well as higher corporate related expenses. | |
| We do not believe the revenue mix changes noted above represent a change in the overall purchasing environment. On top of the potential benefits from the ARRA, we have benefited and hope to continue to benefit from the increased demands on healthcare providers for greater efficiency and lower costs, as well as increased adoption rates for electronic medical records and other technology in the healthcare arena. | |
| While we expect to benefit from the increasing demands for greater efficiency as well as government support for increased adoption of electronic health records, the current economic environment, combined with unpredictability of the federal governments plans to promote increased adoption of electronic medical records, makes the near term achievement of such benefits and, ultimately, their impact on system sales, uncertain. |
NextGen Division
| NextGen Division revenue increased 25.6% in the three months ended June 30, 2010 and divisional operating income (excluding unallocated corporate expenses) increased 19.4% as compared to the prior year period. Organic revenue growth in the NextGen Division was 18.9% for the three months ended June 30, 2010. | |
| The acquisitions of Opus and Sphere in fiscal year 2010 added approximately $3.2 million in revenue for the three months ended June 30, 2010 as compared to the same period a year ago. | |
| Recurring revenue, consisting of maintenance and EDI revenue increased 20.1% to $32.2 million from $26.8 million in the same period a year ago and accounted for 48.9% of total NextGen Division revenue during the three months ended June 30, 2010. In the same period a year ago, recurring revenue represented 51.1% of total divisional revenue. | |
| During the three months ended June 30, 2010, we added staffing resources in anticipation of future growth from the ARRA. We intend to continue doing so in future periods to maximize our opportunities from the ARRA. | |
| Our goals include taking maximum advantage of future benefits related to the ARRA and continuing to further enhance and expand the marketing and sales of our existing products, developing new products for targeted markets, continuing to add new customers, selling additional software and services to existing customers, expanding penetration of connectivity and other services to new and existing customers, and capitalizing on growth and cross selling opportunities within the Practice Solutions Division and the recently acquired acute care software product lines. |
QSI Dental Division
| QSI Dental Division revenue increased 38.8% in the three months ended June 30, 2010 and divisional operating income (excluding unallocated corporate expenses) increased $1.5 million, or 139.6%, from the three months ended June 30, 2009. | |
| An increase in system sales revenue was the chief contributor to the operating income results in the quarter. | |
| In July 2009, we licensed source code from PlanetDDS, Inc. that will allow us to deliver hosted, web-based SaaS practice management and clinical software solutions to the dental industry. The software solution will be marketed primarily to the multi-location dental group practice market in which the QSI Dental Division has historically been a dominant player. This new software solution (NextDDS) brings the QSI Dental Division to the forefront of the emergence of internet based applications and cloud computing and represents a significant growth opportunity for us to sell both to our existing customer base as well as new customers. | |
| Our goal for the QSI Dental Division is to maximize profit performance given the constraints represented by a relatively weak purchasing environment in the dental group practice market while taking advantage of opportunities with the new NextDDS product. The QSI Dental Division also intends to leverage the NextGen Divisions sales force to sell its dental electronic medical records software to practices that provide both medical and dental services such as Federal Qualified Health Centers, which are receiving grants as part of the ARRA. |
Practice Solutions Division
| Practice Solutions Division revenue increased 13.4% in the three months ended June 30, 2010 and divisional operating income (excluding unallocated corporate expenses) decreased 34.4% from the three months ended June 30, 2009. The Practice Solutions Division also benefited from organic growth achieved through cross selling RCM services to existing NextGen Division customers. | |
| Operating income as a percentage of revenue declined to approximately 1.6% of revenue versus 2.8% of revenue primarily as a result of a smaller amount of software sales to RCM customers compared to the prior year as well as costs related to transitioning to the NextGen platform including training of staff and initial set up and other costs related to achieving higher production volumes. |
The following table sets forth for the periods indicated the percentage of net revenue represented
by each item in our consolidated statements of income (certain percentages below may not sum due to
rounding):
24
Table of Contents
Three Months Ended June 30, | ||||||||
(Unaudited) | 2010 | 2009 | ||||||
Revenues: |
||||||||
Software, hardware and supplies |
29.9 | % | 26.7 | % | ||||
Implementation and training services |
5.2 | 5.2 | ||||||
System sales |
35.0 | 31.9 | ||||||
Maintenance |
30.8 | 32.5 | ||||||
Electronic data interchange services |
11.8 | 12.2 | ||||||
Revenue cycle management and related services |
13.0 | 13.5 | ||||||
Other services |
9.4 | 9.9 | ||||||
Maintenance, EDI, RCM and other services |
65.0 | 68.1 | ||||||
Total revenues |
100.0 | 100.0 | ||||||
Cost of revenue: |
||||||||
Software, hardware and supplies |
7.5 | 4.1 | ||||||
Implementation and training services |
3.6 | 4.3 | ||||||
Total cost of system sales |
11.1 | 8.4 | ||||||
Maintenance |
4.2 | 4.5 | ||||||
Electronic data interchange services |
8.1 | 8.8 | ||||||
Revenue cycle management and related services |
9.8 | 9.8 | ||||||
Other services |
5.2 | 7.3 | ||||||
Total cost of maintenance, EDI, RCM and other services |
27.3 | 30.4 | ||||||
Total cost of revenue |
38.4 | 38.8 | ||||||
Gross profit |
61.6 | 61.2 | ||||||
Operating expenses: |
||||||||
Selling, general and administrative |
31.6 | 30.2 | ||||||
Research and development costs |
6.6 | 6.0 | ||||||
Amortization of acquired intangible assets |
0.4 | 0.5 | ||||||
Total operating expenses |
38.6 | 36.7 | ||||||
Income from operations |
22.9 | 24.5 | ||||||
Interest income |
0.1 | 0.1 | ||||||
Other income (expense) |
0.0 | 0.1 | ||||||
Income before provision for income taxes |
23.0 | 24.7 | ||||||
Provision for income taxes |
8.4 | 9.2 | ||||||
Net income |
14.6 | % | 15.5 | % | ||||
Comparison of the Three Months Ended June 30, 2010 and June 30, 2009
Net Income. The Companys net income for the three months ended June 30, 2010 was $12.1 million or
$0.42 per share on a basic and fully diluted basis. In comparison, we earned $10.3 million or
$0.36 per share on a basic and fully diluted basis for the three months ended June 30, 2009. The
increase in net income for the three months ended June 30, 2010 was achieved primarily through the
following:
| a 24.4% increase in consolidated revenue, including an increase of $13.4 million in revenue from our NextGen Division, an increase of $1.5 million from our QSI Dental Division, and an increase of $1.4 million in revenue from our Practice Solutions Division; | |
| a 25.6% increase in NextGen Division revenue, which accounted for 79.4% of consolidated revenue; | |
| an increase of recurring revenue, including RCM, maintenance, and EDI revenue, offset by a decline in our gross profit margin due primarily to both a shift in revenue mix with increased hardware and RCM revenue, and | |
| an increase in selling, general and administrative expenses as a percentage of revenue related to higher selling and corporate expenses. |
Revenue. Revenue for the three months ended June 30, 2010 increased 24.4% to $82.9 million from
$66.6 million for the three months ended June 30, 2009. NextGen Division revenue increased 25.6%
to $65.8 million from $52.4 million in the three months ended June 30, 2009 while QSI Dental
Division revenue increased 38.8% during that same period to $5.4 million from $3.9 million and
Practice Solutions Division revenue increased 13.4% during that same period to $11.7 million from
$10.4 million.
System Sales. Revenue earned from Company-wide sales of systems for the three months ended June
30, 2010 increased 36.9% to $29.1 million from $21.2 million in the prior year period.
25
Table of Contents
Our increase in revenue from sales of systems was principally the result of a 32.5% increase in
category revenue at our NextGen Division whose sales in this category increased from $20.3 million
during the three months ended June 30, 2009 to $26.9 million during the three months ended June 30,
2010. This increase was driven by higher sales of ambulatory practice management and health
records software to both new and existing clients, as well as increases in revenue related to
implementation and training services.
The following table breaks down our reported system sales into software, hardware, third party
software, supplies, and implementation and training services components by division (in thousands):
Hardware, Third | Implementation | |||||||||||||||
Party Software | and Training | Total System | ||||||||||||||
Software | and Supplies | Services | Sales | |||||||||||||
Three months ended June 30, 2010 |
||||||||||||||||
QSI Dental Division |
$ | 874 | $ | 883 | $ | 236 | $ | 1,993 | ||||||||
NextGen Division |
19,610 | 3,236 | 4,020 | 26,866 | ||||||||||||
Practice Solutions Division |
153 | | 52 | 205 | ||||||||||||
Consolidated |
$ | 20,637 | $ | 4,119 | $ | 4,308 | $ | 29,064 | ||||||||
Three months ended June 30, 2009 |
||||||||||||||||
QSI Dental Division |
$ | 182 | $ | 253 | $ | 209 | $ | 644 | ||||||||
NextGen Division |
15,987 | 1,096 | 3,193 | 20,276 | ||||||||||||
Practice Solutions Division |
258 | | 55 | 313 | ||||||||||||
Consolidated |
$ | 16,427 | $ | 1,349 | $ | 3,457 | $ | 21,233 | ||||||||
NextGen Division software license revenue increased 22.7% in the three months ended June 30, 2010
versus the same period last year. The Divisions software revenue accounted for 73.0% of
divisional system sales revenue during the three months ended June 30, 2010, compared to 78.8%
during the same period a year ago. Software license revenue growth continues to be an area of
primary emphasis for the NextGen Division. The Opus acquisition contributed approximately $0.9
million to the NextGen Divisions software license revenue during the three months ended June 30,
2010.
During the three months ended June 30, 2010, 12.0% of NextGen Divisions system sales revenue was
represented by hardware and third party software compared to 5.4% during same period a year ago.
The increase in hardware and third party software revenue was a result of previously backordered
hardware that was shipped during the quarter ended June 30, 2010. The number of customers who
purchase hardware and third party software and the dollar amount of hardware and third party
software revenue fluctuates each quarter depending on the needs of customers. The inclusion of
hardware and third party software in the Divisions sales arrangements is typically at the request
of our customers.
Implementation and training revenue related to system sales at the NextGen Division increased 25.9%
in the three months ended June 30, 2010 compared the prior year period. The amount of
implementation and training services revenue is dependent on several factors, including timing of
customer implementations, the availability of qualified staff, and the mix of services being
rendered. The number of implementation and training staff increased during the three months ended
June 30, 2010 versus 2009 in order to accommodate the increased amount of implementation services
sold in conjunction with increased software sales. In order to achieve growth in this area,
additional staffing increases and additional training facilities are anticipated, though actual
future increases in revenue and staff will depend upon the availability of qualified staff,
business mix and conditions, and our ability to retain current staff members.
The NextGen Divisions growth has come in part from investments in sales and marketing activities
including a revamped NextGen.com Web site, new NextGen logo, new marketing campaigns, trade show
attendance, and other expanded advertising and marketing expenditures. We have also benefited from
winning numerous industry awards for the NextGen Divisions flagship NextGenehr and
NextGenepm software products and the increasing acceptance of electronic medical records
technology in the healthcare industry.
For the QSI Dental Division, total system sales increased $1.4 million, or 209.5%, to $2.0 million
in the three months ended June 30, 2010 as compared to $0.6 million the prior year period. Systems
sales in the QSI Dental Division were positively impacted by greater joint sales of dental and
medical software to Federally Qualified Health Centers. In addition, the Division began selling
the SaaS based NextDDS product during fiscal year 2010.
For the Practice Solutions Division, total system sales decreased by 34.5% in the three months
ended June 30, 2010 as compared to the prior year period. Systems sales revenue within the
Practice Solutions Division is composed of sales to existing RCM customers only.
Maintenance, EDI, RCM and Other Services. For the three months ended June 30, 2010, Company-wide
revenue from maintenance, EDI, RCM and other services grew 18.6% to $53.9 million from $45.4
million in the prior year period. The increase in this category resulted primarily from an
increase in maintenance, EDI and other services revenue from the NextGen Division and RCM revenue
from the Practice Solutions Division. Total NextGen Division maintenance revenue for the three
months ended June 30, 2010 grew 19.2% to $23.7 million from $19.9 million in the same prior year
period while EDI revenue grew 22.7% to $8.5 million compared to $7.0 million during the same prior
year period. Other services revenue for the NextGen Division for the three months ended June 30,
2010, which consists primarily of third party annual software license renewals, and hosting
services increased 26.6% to $6.8 million from $5.3 million in the same prior year period, primarily
due to increases in third party annual software licenses, consulting services and hosting services
revenue.
26
Table of Contents
QSI Dental Division maintenance, EDI and other revenue remained fairly consistent at $3.4
million in the three months ended June 30, 2010 as compared to $3.2 million in the three months
ended June 30, 2009. For the three months ended June 30, 2010, RCM revenue grew $1.8 million to
$10.8 million compared to $9.0 million in the prior year period.
The following table details maintenance, EDI, RCM, and other services revenue by category for the
three months ended June 30, 2010 and 2009 (in thousands):
Maintenance | EDI | RCM | Other | Total | ||||||||||||||||
Three months ended June 30, 2010 |
||||||||||||||||||||
QSI Dental Division |
$ | 1,837 | $ | 1,224 | $ | | $ | 298 | $ | 3,359 | ||||||||||
NextGen Division |
23,661 | 8,540 | | 6,763 | 38,964 | |||||||||||||||
Practice Solutions Division |
38 | | 10,772 | 730 | 11,540 | |||||||||||||||
Consolidated |
$ | 25,536 | $ | 9,764 | $ | 10,772 | $ | 7,791 | $ | 53,863 | ||||||||||
Three months ended June 30, 2009 |
||||||||||||||||||||
QSI Dental Division |
$ | 1,781 | $ | 1,203 | $ | | $ | 228 | $ | 3,212 | ||||||||||
NextGen Division |
19,856 | 6,958 | | 5,340 | 32,154 | |||||||||||||||
Practice Solutions Division |
3 | | 8,992 | 1,044 | 10,039 | |||||||||||||||
Consolidated |
$ | 21,640 | $ | 8,161 | $ | 8,992 | $ | 6,612 | $ | 45,405 | ||||||||||
The growth in maintenance revenue for the NextGen Division has come from new customers that have
been added each quarter, existing customers who have purchased additional licenses, and our
relative success in retaining existing maintenance customers. NextGens EDI revenue growth has
come from new customers and from further penetration of the Divisions existing customer base. The
growth in RCM revenue has come from new customers that have been acquired from cross selling
opportunities with the NextGen customer base. We intend to continue to promote maintenance, EDI
and RCM services to both new and existing customers.
Cost of Revenue. Cost of revenue for the three months ended June 30, 2010 increased 23.1% to $31.9
million from $25.9 million in the three months ended June 30, 2009 and the cost of revenue as a
percentage of revenue decreased slightly to 38.4% from 38.9% due to the fact that the rate of
growth in cost of revenue grew slower than the aggregate revenue growth rate for the Company.
The following table details revenue and cost of revenue on a consolidated and divisional basis for
the three months ended June 30, 2010 and 2009 (in thousands):
Three Months Ended June 30, | ||||||||||||||||
2010 | % | 2009 | % | |||||||||||||
QSI Dental Division |
||||||||||||||||
Revenue |
$ | 5,352 | 100.0 | % | $ | 3,856 | 100.0 | % | ||||||||
Cost of revenue |
2,392 | 44.7 | % | 1,791 | 46.4 | % | ||||||||||
Gross profit |
$ | 2,960 | 55.3 | % | $ | 2,065 | 53.6 | % | ||||||||
NextGen Division |
||||||||||||||||
Revenue |
$ | 65,830 | 100.0 | % | $ | 52,430 | 100.0 | % | ||||||||
Cost of revenue |
21,064 | 32.0 | % | 16,604 | 31.7 | % | ||||||||||
Gross profit |
$ | 44,766 | 68.0 | % | $ | 35,826 | 68.3 | % | ||||||||
Practice Solutions Division |
||||||||||||||||
Revenue |
$ | 11,745 | 100.0 | % | $ | 10,352 | 100.0 | % | ||||||||
Cost of revenue |
8,403 | 71.5 | % | 7,494 | 72.4 | % | ||||||||||
Gross profit |
$ | 3,342 | 28.5 | % | $ | 2,858 | 27.6 | % | ||||||||
Consolidated |
||||||||||||||||
Revenue |
$ | 82,927 | 100.0 | % | $ | 66,638 | 100.0 | % | ||||||||
Cost of revenue |
31,859 | 38.4 | % | 25,889 | 38.9 | % | ||||||||||
Gross profit |
$ | 51,068 | 61.6 | % | $ | 40,749 | 61.1 | % | ||||||||
Gross profit margins at the NextGen Division for the three months ended June 30, 2010 remained
fairly consistent at 68.0% compared to 68.3% for the three months ended June 30, 2009. Gross
profit margins at the QSI Dental Division for the three months ended June 30, 2010 increased to
55.3% from 53.6% for the three months ended June 30, 2009 as result of a lower percentage of
payroll and related
27
Table of Contents
benefits and EDI costs in the three months ended June 30, 2010 as compared to the same period a
year ago. Gross margin in the Practice Solutions Division increased to 28.5% for the three months
ended June 30, 2010 as compared to 27.6% in the prior year period.
The following table details the individual components of cost of revenue and gross profit as a
percentage of total revenue on a consolidated and divisional basis for the three months ended June
30, 2010 and 2009:
Hardware, | Payroll and | |||||||||||||||||||||||
Third Party | Related | Total Cost | ||||||||||||||||||||||
Software | Benefits | EDI | Other | of Revenue | Gross Profit | |||||||||||||||||||
Three months ended June 30, 2010 |
||||||||||||||||||||||||
QSI Dental Division |
11.6 | % | 14.4 | % | 12.5 | % | 6.2 | % | 44.7 | % | 55.3 | % | ||||||||||||
NextGen Division |
4.4 | % | 13.8 | % | 8.8 | % | 5.0 | % | 32.0 | % | 68.0 | % | ||||||||||||
Practice Solutions Division |
0.0 | % | 44.4 | % | 0.0 | % | 27.1 | % | 71.5 | % | 28.5 | % | ||||||||||||
Consolidated |
4.2 | % | 18.1 | % | 7.8 | % | 8.3 | % | 38.4 | % | 61.6 | % | ||||||||||||
Three months ended June 30, 2009 |
||||||||||||||||||||||||
QSI Dental Division |
8.0 | % | 15.6 | % | 17.4 | % | 5.5 | % | 46.4 | % | 53.6 | % | ||||||||||||
NextGen Division |
2.9 | % | 12.9 | % | 10.8 | % | 5.1 | % | 31.7 | % | 68.3 | % | ||||||||||||
Practice Solutions Division |
0.1 | % | 47.2 | % | 0.0 | % | 25.1 | % | 72.4 | % | 27.6 | % | ||||||||||||
Consolidated |
2.8 | % | 18.3 | % | 9.5 | % | 8.2 | % | 38.9 | % | 61.1 | % | ||||||||||||
The decrease in our consolidated cost of revenue as a percentage of revenue between the three
months ended June 30, 2010 and 2009 is primarily attributable to lower consolidated EDI costs as a
percentage of revenue, offset by an increase in RCM revenue, which carries higher payroll and
related benefits as a percentage of revenue and an increase in hardware and third party software as
a percentage of revenue. Other expense, which consists of outside service costs, amortization of
software development costs and other costs, remained at 8.3% of total revenue during the three
months ended June 30, 2010 as compared to the same period a year ago.
During the three months ended June 30, 2010, hardware and third party software constituted a higher
portion of cost of revenue compared to the prior year period in the NextGen Division. The increase
in hardware and third party software cost was a result of previously backordered hardware that was
shipped during the quarter ended June 30, 2010. The number of customers who purchase hardware and
third party software and the dollar amount of hardware and third party software purchased
fluctuates each quarter depending on the needs of our customers.
Our payroll and benefits expense associated with delivering our products and services decreased
slightly to 18.1% of consolidated revenue in the three months ended June 30, 2010 compared to 18.3%
during the same period last year.
The absolute level of consolidated payroll and benefit expenses grew from $12.2 million in the
three months ended June 30, 2009 to $15.1 million in the three months ended June 30, 2010, an
increase of 23.1% or approximately $2.8 million. Of the $2.8 million increase, approximately $0.3
million of the increase is related to the Practice Solutions Division. RCM is a service business,
which inherently has higher percentage of payroll costs as a percentage of revenue. For the
NextGen Division, an increase of approximately $2.3 million was related to increased headcount and
payroll and benefits expense associated with delivering products and services. Payroll and
benefits expense associated with delivering products and services in the QSI Dental Division
increased $0.2 million from $0.6 million in the three months ended June 30, 2009 to $0.8 million in
the three months ended June 30, 2010.
As a result of the foregoing events and activities, the gross profit percentage for the Company
increased for the three months ended June 30, 2010 versus the prior year period.
We anticipate continued additions to headcount in all three divisions in areas related to
delivering products and services in future periods, but due to the uncertainties in the timing of
our sales arrangements, our sales mix, the acquisition and training of qualified personnel, and
other issues, we cannot accurately predict if related headcount expense as a percentage of revenue
will increase or decrease in the future.
Selling, General and Administrative Expenses. Selling, general and administrative expenses for the
three months ended June 30, 2010 increased 30.6% to $26.2 million as compared to $20.1 million for
the prior year period. The increase in these expenses resulted primarily from:
| $5.6 million increase in salaries, commissions, and related expenses primarily as a result of headcount additions; | ||
| $1.2 million increase due to a full quarter of selling and administrative expenses from Opus, which was acquired on February 10, 2010; | ||
| $0.8 million increase in business integration related costs; partially offset by | ||
| $0.8 million decrease in legal, accounting, and outside services expenses, and | ||
| $0.7 million decrease in other selling and administrative expenses. |
Share-based compensation expense was approximately $1.0 million and $0.4 million for the three
months ended June 30, 2010 and 2009, respectively, and is included in the aforementioned amounts.
Selling, general and administrative expenses as a percentage of revenue increased from 30.2% in the
three months ended June 30, 2009 to 31.6% in the three months ended June 30, 2010.
28
Table of Contents
We anticipate increased expenditures for trade shows, advertising and the employment of additional
sales and administrative staff at the NextGen Division. We also anticipate future increases in
corporate expenditures being made in a wide range of areas including professional services and
investments in system applications across the Company. While we expect selling, general and
administrative expenses to increase on an absolute basis, we cannot accurately predict the impact
these additional expenditures will have on selling, general and administrative expenses as a
percentage of revenue.
Research and Development Costs. Research and development costs for the three months ended June 30,
2010 and 2009 were $5.5 million and $4.0 million, respectively. The increases in research and
development expenses were due in part to increased investment in the NextGen Division product line.
The Opus acquisition added $0.6 million in research and development expenses during the period
ended June 30, 2010. Additions to capitalized software costs offset research and development
costs. For the three months ended June 30, 2010, $2.5 million was added to capitalized software
costs while $1.4 million was capitalized during the three months ended June 30, 2009. Research and
development costs as a percentage of revenue increased to 6.6% in the three months ended June 30,
2010 from 6.0% for the same period in 2009. Research and development expenses are expected to
continue at or above current dollar levels. The application of ASC 718 did not have a significant
effect to research and development costs in the three months ended June 30, 2010 and 2009.
Interest Income. Interest income for the three months ended June 30, 2010 remained consistent at
$0.1 million compared to the three months ended June 30, 2009.
Our investment policy is determined by our Board of Directors. We currently maintain our cash in
very liquid short term assets including tax exempt and taxable money market funds. We owned
approximately $7.7 million in ARS as of June 30, 2010, which were sold back to UBS and settled on
July 1, 2010 at 100% of the $7.7 million par value. Our Board of Directors continues to review
alternate uses for our cash including, but not limited to, payment of a special dividend,
initiation of a stock buyback program, an expansion of our investment policy to include investments
with longer maturities of greater than 90 days, or other items. Additionally, it is possible that
we will utilize some or all of our cash to fund acquisitions or other similar business activities.
Any or all of these programs could significantly impact our investment income in future periods.
Other Income (Expense). Other income (expense) for the three months ended June 30, 2010 consists
of gains and losses in fair value recorded on our ARS investments as well as on our ARS put option
rights. We recorded an overall loss on our ARS and ARS put option rights of approximately $6,000.
Provision for Income Taxes. The provision for income taxes for the three months ended June 30,
2010 was approximately $7.0 million as compared to approximately $6.1 million for the corresponding
period a year ago. The effective tax rates were 36.6% and 37.1% for the three months ended June
30, 2010 and 2009, respectively. The effective rate for the three months ended June 30, 2010
decreased from the prior year primarily due to fluctuations in the state effective tax rate,
increased benefits from the qualified production activities deduction, and the expiration of the
federal research and development tax credit statute, which occurred at the end of the fourth
quarter of fiscal year 2010 and therefore was not included in the current year first quarter
provision.
Liquidity and Capital Resources
The following table presents selected financial statistics and information for each of the three
months ended June 30, 2010 and 2009 (dollar amounts in thousands):
Three Months Ended June 30, | ||||||||
2010 | 2009 | |||||||
Cash and cash equivalents |
$ | 93,208 | $ | 77,424 | ||||
Net increase in cash and cash equivalents |
$ | 8,597 | $ | 7,244 | ||||
Net income |
$ | 12,092 | $ | 10,346 | ||||
Net cash provided by operating activities |
$ | 19,366 | $ | 15,514 | ||||
Number of days of sales outstanding |
123 | 127 |
Cash Flows from Operating Activities
Cash provided by operations has historically been our primary source of cash and has primarily been
driven by our net income plus adjustments to add back non-cash expenses, including depreciation,
amortization of intangibles and capitalized software costs, provisions for bad debts and inventory
obsolescence, share-based compensation and deferred taxes.
The following table summarizes our consolidated statements of cash flows for the three months ended
June 30, 2010 and 2009 (in thousands):
29
Table of Contents
Three Months Ended June 30, | ||||||||
2010 | 2009 | |||||||
Net income |
$ | 12,092 | $ | 10,346 | ||||
Non-cash expenses |
5,049 | 3,483 | ||||||
Change in deferred revenue |
(214 | ) | (1,476 | ) | ||||
Change in accounts receivable |
(4,924 | ) | (3,212 | ) | ||||
Change in other assets and liabilities |
7,363 | 6,373 | ||||||
Net cash provided by operating activities |
$ | 19,366 | $ | 15,514 | ||||
Net Income. As referenced in the above table, net income makes up the majority of our cash
generated from operations for the three months ended June 30, 2010 and 2009. The NextGen
Divisions contribution to net income has increased each year due to that Divisions operating
income increasing more quickly than our Company as a whole.
Non-Cash Expenses. Non-cash expenses include depreciation, amortization of intangibles and
capitalized software costs, provisions for bad debts, share-based compensation and deferred taxes.
Total non-cash expenses were $5.0 million and $3.5 million for the three months ended June 30, 2010
and 2009, respectively. The $1.6 million increase in non-cash expenses for the three months ended
June 30, 2010 as compared to the prior year period is primarily related to an increase of
approximately $0.1 million in depreciation, $0.2 million of amortization of capitalized software
costs, $0.4 million of amortization of other intangibles, $0.6 million in share-based compensation
and $0.3 million in deferred income tax benefit.
Deferred Revenue. Cash from operations was negatively impacted from decreases in deferred revenue
primarily due to a decrease in the volume of implementation and maintenance services invoiced by
the NextGen Division which had not yet been rendered or recognized as revenue. Deferred revenue
decreased by approximately $0.2 million for the three months ended June 30, 2010 versus a decrease
of $1.5 million in the prior year period, resulting in decreases to cash from operations in the
prior year quarter.
Accounts Receivable. Accounts receivable grew by approximately $4.9 million and $3.2 million for
the three months ended June 30, 2010 and 2009, respectively. The increase in accounts receivable
in the periods is due to the following factors:
| NextGen Division revenue grew 25.6% and 20.7% on a year-over-year basis, in the three months ended June 30, 2010 and 2009, respectively; and | |
| Turnover of accounts receivable is generally slower in the NextGen Division due to the fact that the systems sales related revenue have longer payment terms, generally up to one year, which historically have accounted for a major portion of NextGen Division sales. |
The turnover of accounts receivable measured in terms of days sales outstanding (DSO) decreased
from 127 days to 123 days during the three months ended June 30, 2010. The decrease in DSO is
primarily due to an increase in recurring revenue, such as maintenance, EDI and RCM revenue, which
has a faster turnover of accounts receivable compared to system sales.
If amounts included in both accounts receivable and deferred revenue were netted, our turnover of
accounts receivable expressed as DSO would be 80 days as of June 30, 2010 and 88 days as of June
30, 2009. Provided turnover of accounts receivable, deferred revenue, and profitability remain
consistent with the three months ended June 30, 2010, we anticipate being able to continue to
generate cash from operations during fiscal 2011 primarily from our net income.
Cash Flows from Investing Activities
Net cash used in investing activities for the three months ended June 30, 2010 and 2009 was $3.4
million and $3.1 million, respectively. The increase in cash used in investing activities during
the three months period ended June 30, 2010 is the result of $2.5 million in additions to
capitalized software, offset by $0.9 million in additions to equipment and improvements.
Cash Flows from Financing Activities
Net cash used in financing activities for the three months ended June 30, 2010 was $7.3 million and
consisted of dividends paid to shareholders totaling $8.7 million, offset by proceeds of $1.1
million from the exercise of stock options. We recorded a reduction in our income tax liability of
$0.2 million related to excess tax deductions received from stock option exercises. The benefit
was recorded as additional paid in capital.
Cash and Cash Equivalents and Marketable Securities
At June 30, 2010, we had cash and cash equivalents of $93.2 million and marketable securities of
$7.7 million. We intend to expend some of these funds for the development of products
complementary to our existing product line as well as new versions of certain of our
products. These developments are intended to take advantage of more powerful technologies and to
increase the integration of our products. We have no additional significant current capital
commitments.
In January 2007, our Board of Directors adopted a policy whereby we intend to pay a regular
quarterly dividend of $0.25 per share on our outstanding Common Stock, subject to further Board
review and approval and establishment of record and distribution dates by our Board of Directors
prior to the declaration of each such quarterly dividend. In August 2008, our Board of Directors
increased the quarterly
30
Table of Contents
dividend to $0.30 per share. We anticipate that future quarterly
dividends, if and when declared by our Board of Directors pursuant to this policy, would likely be
distributable on or about the fifth day of each of the months of October, January, April and July.
On July 28, 2010, the Board of Directors approved a quarterly cash dividend of $0.30 per share on
the Companys outstanding shares of Common Stock, payable to shareholders of record as of September
17, 2010 with an expected distribution date on or about October 5, 2010.
The following dividends have been declared in the 2011, 2010, and 2009 fiscal years on the dates
indicated:
Board Approval Date | Record Date | Payment Date | Dividend Amount | |||||
Fiscal year 2011 |
||||||||
May 26, 2010
|
June 17, 2010 | July 6, 2010 | $ | 0.30 | ||||
Fiscal year 2010 |
||||||||
January 27, 2010
|
March 23, 2010 | April 5, 2010 | $ | 0.30 | ||||
October 28, 2009
|
December 23, 2009 | January 5, 2010 | 0.30 | |||||
July 23, 2009
|
September 25, 2009 | October 5, 2009 | 0.30 | |||||
May 27, 2009
|
June 12, 2009 | July 6, 2009 | 0.30 | |||||
Fiscal year 2009 |
||||||||
January 28, 2009
|
March 11, 2009 | April 3, 2009 | $ | 0.30 | ||||
October 30, 2008
|
December 15, 2008 | January 5, 2009 | 0.30 | |||||
August 4, 2008
|
September 15, 2008 | October 1, 2008 | 0.30 | |||||
May 29, 2008
|
June 15, 2008 | July 2, 2008 | 0.25 |
Management believes that its cash and cash equivalents on hand at June 30, 2010, together with its
marketable securities and cash flows from operations, if any, will be sufficient to meet its
working capital and capital expenditure requirements as well as any dividends to be paid in the
ordinary course of business for the remainder of fiscal year 2011.
Contractual Obligations
The following table summarizes our significant contractual obligations, all of which relate to
operating leases, at June 30, 2010 and the effect that such obligations are expected to have on our
liquidity and cash in future periods:
Year ended March 31, | ||||
2011 (remaining nine months) |
$ | 3,412 | ||
2012 |
4,595 | |||
2013 |
4,628 | |||
2014 |
4,015 | |||
2015 and beyond |
7,250 | |||
$ | 23,900 | |||
New Accounting Pronouncements
Refer to Note 2 of our Notes to Consolidated Financial Statements, Summary of Significant
Accounting Policies, for a discussion of new accounting standards.
ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISKS
We currently maintain our cash in very liquid short term assets including tax exempt and taxable
money market funds. We maintain investments in tax exempt municipal ARS. At June 30, 2010, we had
approximately $7.7 million of ARS, which were sold back to UBS and settled on July 1, 2010 at 100%
of the $7.7 million par value.
ITEM 4. CONTROLS AND PROCEDURES
Evaluation of Disclosure Controls and Procedures
Our Chief Executive Officer and Chief Financial Officer (our principal executive officer and
principal financial officer, respectively) have evaluated the effectiveness of the Companys
disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Security
Exchange Act of 1934, as amended) as of June 30, 2010, the end of the period covered by the
Quarterly Report (the Evaluation Date). They have concluded that, as of the Evaluation Date,
these disclosure controls and procedures were effective to ensure that material information
relating to the Company and its consolidated subsidiaries would be made known to them by others
within those entities and would be disclosed on a timely basis. The Chief Executive Officer and
Chief Financial Officer have concluded that the Companys disclosure controls and procedures are
designed, and are effective, to give reasonable assurance that the information required to be
disclosed by the Company in reports that it files under the Exchange Act is recorded, processed,
summarized and reported within the
31
Table of Contents
time period specified in the rules and forms of the SEC. They
have also concluded that the Companys disclosure controls and procedures are effective to ensure
that information required to be disclosed in the reports that are filed or submitted under the
Exchange Act are accumulated and communicated to the Companys management, including the Chief
Executive Officer and Chief Financial Officer, to allow timely decisions regarding required
disclosure.
Changes in Internal Control over Financial Reporting
During the quarter ended June 30, 2010, there were no changes in our internal control over
financial reporting (as defined in Rule 13a-15(f) under the Exchange Act) that have materially
affected, or are reasonably likely to materially affect, our internal control over financial
reporting.
The Companys management, including its Chief Executive Officer and Chief Financial Officer, has
concluded that our disclosure controls and procedures and internal control over financial reporting
are designed to provide reasonable assurance of achieving their objectives and are effective at
that reasonable assurance level. However, the Companys management can provide no assurance that
our disclosure controls and procedures or our internal control over financial reporting can prevent
all errors and all fraud under all circumstances. A control system, no matter how well conceived
and operated, can provide only reasonable, not absolute, assurance that the objectives of the
control system are met. Further, the design of a control system must reflect the fact that there
are resource constraints, and the benefits of controls must be considered relative to their costs.
Because of the inherent limitations in all control systems, no evaluation of controls can provide
absolute assurance that all control issues and instances of fraud, if any, within the Company have
been or will be detected. The design of any system of controls also is based in part upon certain
assumptions about the likelihood of future events, and there can be no assurance that any design
will succeed in achieving its stated goals under all potential future conditions; over time,
controls may become inadequate because of changes in conditions, or the degree of compliance with
policies or procedures may deteriorate. Because of the inherent limitations in a cost-effective
control system, misstatements due to error or fraud may occur and not be detected.
32
Table of Contents
PART II
OTHER INFORMATION
OTHER INFORMATION
ITEM 1. LEGAL PROCEEDINGS
We have experienced legal claims by parties asserting that we have infringed their intellectual
property rights. We believe that these claims are without merit and intend to defend against them
vigorously; however, we could incur substantial costs and diversion of management resources
defending any infringement claim even if we are ultimately successful in the defense of such
matter. Litigation is inherently uncertain and always difficult to predict. We refer you to the
discussion of infringement and litigation risks in our Risk Factors section of our Annual Report on
Form 10-K.
ITEM 1A. RISK FACTORS
None.
ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS
None.
ITEM 3. DEFAULTS UPON SENIOR SECURITIES
None.
ITEM 4. RESERVED
None.
ITEM 5. OTHER INFORMATION
None.
33
Table of Contents
ITEM 6. EXHIBITS
Exhibit | ||
Number | Description | |
31.1*
|
Certification of Principal Executive Officer Required by Rule 13a-14(a) of the Securities Exchange Act of 1934, as amended, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. | |
31.2*
|
Certification of Principal Financial Officer Required by Rule 13a-14(a) of the Securities Exchange Act of 1934, as amended, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. | |
32.1*
|
Certification of Chief Executive Officer and Chief Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. | |
**101.INS
|
XBRL Instance | |
**101.SCH
|
XBRL Taxonomy Extension Schema | |
**101.CAL
|
XBRL Taxonomy Extension Calculation | |
**101.LAB
|
XBRL Taxonomy Extension Label | |
**101.PRE
|
XBRL Taxonomy Extension Presentation | |
**101.DEF
|
XBRL Taxonomy Extension Definition |
* | Filed herewith. | |
** | XBRL information is furnished and not filed or a part of a registration statement or prospectus for purposes of section 11 or 12 of the Securities and Exchange Act of 1933, as amended, is deemed not filed for purposes of section 18 of the Securities and Exchange Act of 1034, as amended, and otherwise is not subject to liability under these section. |
34
Table of Contents
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, we have duly caused this
Report to be signed on its behalf by the undersigned thereunto duly authorized.
QUALITY SYSTEMS, INC. |
||||
Date: August 2, 2010 | By: | /s/ Steven T. Plochocki | ||
Steven T. Plochocki | ||||
Chief Executive Officer (Principal Executive Officer) |
||||
Date: August 2, 2010 | By: | /s/ Paul A. Holt | ||
Paul A. Holt | ||||
Chief Financial Officer (Principal Accounting Officer) |
35